The metabolic syndrome.

[1]  A. Scheen.  Prevention of Type 2 Diabetes Mellitus Through Inhibition of the Renin-Angiotensin System , 2012, Drugs.

[2]  O. Ljungqvist.  Metabolic Regulation: A Human Perspective , 2011 .

[3]  Masato Kasuga,et al.  [Obesity and insulin resistance]. , 2009, Nihon rinsho. Japanese journal of clinical medicine.

[4]  M. Marmot,et al.  Social inequality in coronary risk: Central obesity and the metabolic syndrome. Evidence from the Whitehall II study , 1997, Diabetologia.

[5]  A. Nicolucci,et al.  The Italian Diabetes and Exercise Study (IDES): design and methods for a prospective Italian multicentre trial of intensive lifestyle intervention in people with type 2 diabetes and the metabolic syndrome. , 2008, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[6]  R. Holman,et al.  10-year follow-up of intensive glucose control in type 2 diabetes. , 2008, The New England journal of medicine.

[7]  U. Lindblad,et al.  Retinopathy in subjects with impaired fasting glucose: the NANSY‐Eye baseline report , 2008, Diabetes, obesity & metabolism.

[8]  P. Macfarlane,et al.  Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies , 2008, The Lancet.

[9]  W. Pan,et al.  Astrocyte leptin receptor (ObR) and leptin transport in adult-onset obese mice. , 2008, Endocrinology.

[10]  R. Geffers,et al.  Hypermetabolic syndrome as a consequence of repeated psychological stress in mice. , 2008, Endocrinology.

[11]  K. Parker,et al.  Selective loss of leptin receptors in the ventromedial hypothalamic nucleus results in increased adiposity and a metabolic syndrome. , 2008, Endocrinology.

[12]  R. Eckel.  Clinical practice. Nonsurgical management of obesity in adults. , 2008, The New England journal of medicine.

[13]  S. Grundy.  Metabolic Syndrome Pandemic , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[14]  C. Yılmaz,et al.  Polymorphism of the interleukin‐10 gene in polycystic ovary syndrome , 2008, International journal of immunogenetics.

[15]  K. Gollahon,et al.  Hyperinsulinemia and insulin resistance in Wrn null mice fed a diabetogenic diet , 2008, Mechanisms of Ageing and Development.

[16]  H. Jacob,et al.  Effects of chromosome 17 on features of the metabolic syndrome in the Lyon hypertensive rat. , 2008, Physiological genomics.

[17]  C. Champagne,et al.  Increased visceral fat and decreased energy expenditure during the menopausal transition , 2008, International Journal of Obesity.

[18]  T. Yanagita,et al.  Dietary phosphatidylinositol prevents the development of nonalcoholic fatty liver disease in Zucker (fa/fa) rats. , 2008, Journal of agricultural and food chemistry.

[19]  P. Formisano,et al.  Atypical protein kinase C dysfunction and the metabolic syndrome , 2008, Trends in Endocrinology & Metabolism.

[20]  M. Kristenson,et al.  The Prevalence of the Metabolic Syndrome and Its Risk Factors in a Middle-Aged Swedish Population — Mainly a Function of Overweight? , 2008, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.

[21]  Y. Naito,et al.  A Mouse Model of Metabolic Syndrome; Increase in Visceral Adipose Tissue Precedes the Development of Fatty Liver and Insulin Resistance in High-Fat Diet-Fed Male KK/Ta Mice , 2008, Journal of clinical biochemistry and nutrition.

[22]  A. J. Valente,et al.  Interleukin-18 Suppresses Adiponectin Expression in 3T3-L1 Adipocytes via a Novel Signal Transduction Pathway Involving ERK1/2-dependent NFATc4 Phosphorylation* , 2008, Journal of Biological Chemistry.

[23]  J. Stevens,et al.  Dietary Intake and the Development of the Metabolic Syndrome: The Atherosclerosis Risk in Communities Study , 2008, Circulation.

[24]  G. Stephanopoulos,et al.  Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis. , 2008, Cell metabolism.

[25]  C. Glueck,et al.  Metabolic syndrome in childhood predicts adult metabolic syndrome and type 2 diabetes mellitus 25 to 30 years later. , 2008, The Journal of pediatrics.

[26]  Terry T. Huang.  Finding thresholds of risk for components of the pediatric metabolic syndrome. , 2008, The Journal of pediatrics.

[27]  E. Ford,et al.  Metabolic syndrome rates in United States adolescents, from the National Health and Nutrition Examination Survey, 1999-2002. , 2008, The Journal of pediatrics.

[28]  E. Ford,et al.  Defining the metabolic syndrome in children and adolescents: will the real definition please stand up? , 2008, The Journal of pediatrics.

[29]  G. Fantuzzi.  Adiponectin and inflammation: consensus and controversy. , 2008, The Journal of allergy and clinical immunology.

[30]  Shumei S. Sun,et al.  Childhood obesity predicts adult metabolic syndrome: the Fels Longitudinal Study. , 2008, The Journal of pediatrics.

[31]  K. Chien,et al.  Prevalence, agreement and classification of various metabolic syndrome criteria among ethnic Chinese: a report on the hospital-based health diagnosis of the adult population. , 2008, Atherosclerosis.

[32]  M. Goran,et al.  Examining metabolic syndrome definitions in overweight Hispanic youth: a focus on insulin resistance. , 2008, The Journal of pediatrics.

[33]  S. Santos,et al.  Mas Deficiency in FVB/N Mice Produces Marked Changes in Lipid and Glycemic Metabolism , 2008, Diabetes.

[34]  B. Davis,et al.  Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). , 2008, Archives of internal medicine.

[35]  Margaret Anderson,et al.  Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. , 2008, JAMA.

[36]  Darren K Mcguire,et al.  New Drugs for the Treatment of Diabetes Mellitus: Part I: Thiazolidinediones and Their Evolving Cardiovascular Implications , 2008, Circulation.

[37]  L. Gooren,et al.  A dose-response study of testosterone on sexual dysfunction and features of the metabolic syndrome using testosterone gel and parenteral testosterone undecanoate. , 2008, Journal of andrology.

[38]  S. Wiedmann,et al.  Genetic Variants Within the LPIN1 Gene, Encoding Lipin, Are Influencing Phenotypes of the Metabolic Syndrome in Humans , 2008, Diabetes.

[39]  M. Elisaf,et al.  Increased plasma visfatin levels in subjects with the metabolic syndrome , 2007, European journal of clinical investigation.

[40]  T. Sørensen,et al.  [Childhood body mass index and the risk of coronary heart disease in adulthood]. , 2007, Ugeskrift for laeger.

[41]  A. Krook,et al.  Role of interleukin‐6 signalling in glucose and lipid metabolism , 2007, Acta physiologica.

[42]  P. Barter,et al.  Is there a role for fibrates in the management of dyslipidemia in the metabolic syndrome? , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[43]  Eric J. Eichhorn.  Simvastatin with or without ezetimibe in familial hypercholesterolemia. , 2008, The New England journal of medicine.

[44]  K. Ohkawara,et al.  A dose–response relation between aerobic exercise and visceral fat reduction: systematic review of clinical trials , 2008, International Journal of Obesity.

[45]  M. Faraj,et al.  Apolipoprotein B, apolipoprotein A-I, insulin resistance and the metabolic syndrome , 2007, Current opinion in lipidology.

[46]  R. Cone,et al.  Obesity-induced inflammation in white adipose tissue is attenuated by loss of melanocortin-3 receptor signaling. , 2007, Endocrinology.

[47]  N. Chalasani,et al.  Use of insulin sensitizers in NASH. , 2007, Endocrinology and metabolism clinics of North America.

[48]  S. Yusuf,et al.  Association between the -455T>C promoter polymorphism of the APOC3 gene and the metabolic syndrome in a multi-ethnic sample , 2007, BMC Medical Genetics.

[49]  R. Holman,et al.  Impact of the Metabolic Syndrome on Macrovascular and Microvascular Outcomes in Type 2 Diabetes Mellitus: United Kingdom Prospective Diabetes Study 78 , 2007, Circulation.

[50]  R. Goldberg,et al.  Prevalence of the metabolic syndrome in Peruvian Andean hispanics: the PREVENCION study. , 2007, Diabetes research and clinical practice.

[51]  C-C Lin,et al.  Microalbuminuria and the metabolic syndrome and its components in the Chinese population , 2007, European journal of clinical investigation.

[52]  M. Hanefeld,et al.  Visfatin: A Putative Biomarker for Metabolic Syndrome is not Influenced by Pioglitazone or Simvastatin Treatment in Nondiabetic Patients at Cardiovascular Risk - Results from the PIOSTAT Study , 2007, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[53]  W. Mckeehan,et al.  FGFR4 Prevents Hyperlipidemia and Insulin Resistance but Underlies High-Fat Diet–Induced Fatty Liver , 2007, Diabetes.

[54]  L. Køber,et al.  Metabolic syndrome and mortality in stable coronary heart disease: relation to gender. , 2007, International journal of cardiology.

[55]  J. Sampalis,et al.  Dyslipidemia: Reduction in Estimated Risk for Coronary Artery Disease After Use of Ezetimibe with a Statin , 2007, The Annals of pharmacotherapy.

[56]  G. Kelley,et al.  Effects of aerobic exercise on lipids and lipoproteins in adults with type 2 diabetes: a meta-analysis of randomized-controlled trials. , 2007, Public health.

[57]  K. Pietiläinen,et al.  Liver fat in the metabolic syndrome. , 2007, The Journal of clinical endocrinology and metabolism.

[58]  J. Shaw,et al.  The metabolic syndrome in Australia: prevalence using four definitions. , 2007, Diabetes research and clinical practice.

[59]  F. Io,et al.  Searching for genetic factors of fatty liver in SMXA-5 mice by quantitative trait loci analysis under a high-fat diet Published, JLR Papers in Press, June 26, 2007. , 2007, Journal of Lipid Research.

[60]  F. Azizi,et al.  Are patients who have metabolic syndrome without diabetes at risk for developing chronic kidney disease? Evidence based on data from a large cohort screening population. , 2007, Clinical journal of the American Society of Nephrology : CJASN.

[61]  M. Burnier,et al.  The association of aldosterone with obesity-related hypertension and the metabolic syndrome. , 2007, Seminars in nephrology.

[62]  P. Libby,et al.  Interleukin-18, the Metabolic Syndrome, and Subclinical Atherosclerosis: Results From the Dallas Heart Study , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[63]  Claude Bouchard,et al.  Effects of bariatric surgery on mortality in Swedish obese subjects. , 2007, The New England journal of medicine.

[64]  Steven C Hunt,et al.  Long-term mortality after gastric bypass surgery. , 2007, The New England journal of medicine.

[65]  E. Hoffman,et al.  PPARα L162V underlies variation in serum triglycerides and subcutaneous fat volume in young males , 2007, BMC Medical Genetics.

[66]  J. Parish,et al.  Relationship of metabolic syndrome and obstructive sleep apnea. , 2007, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[67]  C. Napoli,et al.  The influence of pomegranate fruit extract in comparison to regular pomegranate juice and seed oil on nitric oxide and arterial function in obese Zucker rats. , 2007, Nitric oxide : biology and chemistry.

[68]  Y. Tamura,et al.  Effects of diet-induced moderate weight reduction on intrahepatic and intramyocellular triglycerides and glucose metabolism in obese subjects. , 2007, The Journal of clinical endocrinology and metabolism.

[69]  S. Humphries,et al.  The S447X variant of lipoprotein lipase gene is associated with metabolic syndrome and lipid levels among Turks. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[70]  M. Kramer,et al.  The association of OSA with insulin resistance, inflammation and metabolic syndrome. , 2007, Respiratory medicine.

[71]  P. Ernsberger,et al.  Therapeutic actions of allylmercaptocaptopril and captopril in a rat model of metabolic syndrome. , 2007, American journal of hypertension.

[72]  W. Boon,et al.  Estrogen and adiposity—Utilizing models of aromatase deficiency to explore the relationship , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[73]  C. Kahn,et al.  Muscle-specific knockout of PKC-λ impairs glucose transport and induces metabolic and diabetic syndromes , 2007 .

[74]  Ian J. Brown,et al.  Food Omega-3 Fatty Acid Intake of Individuals (Total, Linolenic Acid, Long-Chain) and Their Blood Pressure: INTERMAP Study , 2007, Hypertension.

[75]  M. Nishida,et al.  Interleukin-10 associates with adiponectin predominantly in subjects with metabolic syndrome. , 2007, Circulation journal : official journal of the Japanese Circulation Society.

[76]  C. Ballantyne,et al.  Meta-analysis of the cholesterol-lowering effect of ezetimibe added to ongoing statin therapy , 2007, Current medical research and opinion.

[77]  M. Hanefeld,et al.  Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis. , 2007, The New England journal of medicine.

[78]  L. Fairbanks,et al.  Characterization and Heritability of Obesity and Associated Risk Factors in Vervet Monkeys , 2007, Obesity.

[79]  Arch G Mainous,et al.  Turning back the clock: adopting a healthy lifestyle in middle age. , 2007, The American journal of medicine.

[80]  G. Balercia,et al.  ORIGINAL RESEARCH—ENDOCRINOLOGY: NCEP‐ATPIII‐Defined Metabolic Syndrome, Type 2 Diabetes Mellitus, and Prevalence of Hypogonadism in Male Patients with Sexual Dysfunction , 2007 .

[81]  L. Manzoli,et al.  Metabolic Syndrome and Cardiovascular Risk in HIV-Infected Patients with Lipodystrophy , 2007, International journal of immunopathology and pharmacology.

[82]  B. Lyoussi,et al.  Metabolic syndrome: treatment of hypertensive patients. , 2007, American journal of therapeutics.

[83]  Y. Khader,et al.  High prevalence of the metabolic syndrome among Northern Jordanians. , 2007, Journal of diabetes and its complications.

[84]  M. Kojima,et al.  Overexpression of human adiponectin in transgenic mice results in suppression of fat accumulation and prevention of premature death by high-calorie diet. , 2007, American journal of physiology. Endocrinology and metabolism.

[85]  B. Balkau,et al.  Metabolic syndrome in a sub-Saharan African setting: central obesity may be the key determinant. , 2007, Atherosclerosis.

[86]  Y. Duan,et al.  Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all‐cause mortality – results of prospective analysis for the Atherosclerosis Risk in Communities study , 2007, Journal of internal medicine.

[87]  A. Zabetian,et al.  Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions. , 2007, Diabetes research and clinical practice.

[88]  S. Nissen,et al.  Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. , 2007, The New England journal of medicine.

[89]  A. Dobs,et al.  Androgen deficiency, diabetes, and the metabolic syndrome in men , 2007, Current opinion in endocrinology, diabetes, and obesity.

[90]  S. Bandinelli,et al.  High interleukin-6 plasma levels are associated with low HDL-C levels in community-dwelling older adults: the InChianti study. , 2007, Atherosclerosis.

[91]  B. Lamarche,et al.  Endothelial lipase and the metabolic syndrome , 2007, Current opinion in lipidology.

[92]  W. Garvey,et al.  Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease , 2007, Current opinion in lipidology.

[93]  B. Hansen,et al.  Nuclear magnetic resonance-determined lipoprotein abnormalities in nonhuman primates with the metabolic syndrome and type 2 diabetes mellitus. , 2007, Metabolism: clinical and experimental.

[94]  R. Eckel.  Treating dyslipidemia of the metabolic syndrome: where's the evidence? , 2007, Nature Clinical Practice Endocrinology &Metabolism.

[95]  V. Polotsky.  Mouse model of the metabolic syndrome: the quest continues. , 2007, Journal of applied physiology.

[96]  R. Bergman,et al.  Nocturnal free fatty acids are uniquely elevated in the longitudinal development of diet-induced insulin resistance and hyperinsulinemia. , 2007, American journal of physiology. Endocrinology and metabolism.

[97]  K. Svenson,et al.  Multiple trait measurements in 43 inbred mouse strains capture the phenotypic diversity characteristic of human populations. , 2007, Journal of applied physiology.

[98]  Z. Bloomgarden.  Nonalcoholic Fatty Liver Disease and Insulin Resistance in Youth , 2007, Diabetes Care.

[99]  G. Bray,et al.  Pharmacological Treatment of the Overweight Patient , 2007, Pharmacological Reviews.

[100]  M. Simoons,et al.  Adverse prognosis associated with the metabolic syndrome in established coronary artery disease: data from the EUROPA trial , 2007, Heart.

[101]  T. Hansen,et al.  Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study. , 2007, Journal of the American College of Cardiology.

[102]  Y. Ohashi,et al.  Effect of aerobic exercise training on serum levels of high-density lipoprotein cholesterol: a meta-analysis. , 2007, Archives of internal medicine.

[103]  Eric Vaillancourt,et al.  Coordinated Regulation of Nutrient and Inflammatory Responses by STAMP2 Is Essential for Metabolic Homeostasis , 2007, Cell.

[104]  M. Uribe,et al.  Current concepts in the pathogenesis of nonalcoholic fatty liver disease , 2007, Liver international : official journal of the International Association for the Study of the Liver.

[105]  S. Humphries,et al.  A common interleukin 18 haplotype is associated with higher body mass index in subjects with diabetes and coronary heart disease. , 2007, Metabolism: clinical and experimental.

[106]  W. Schwesinger,et al.  Metabolic aspects of bariatric surgery. , 2007, The Medical clinics of North America.

[107]  R. Ramanathan,et al.  Impact of obesity and bariatric surgery on cardiovascular disease. , 2007, The Medical clinics of North America.

[108]  J. Schrezenmeir,et al.  Common familial influences on clustering of metabolic syndrome traits with central obesity and insulin resistance: the Kiel obesity prevention study , 2007, International Journal of Obesity.

[109]  J. Lüdemann,et al.  Impaired coronary function in Wistar Ottawa Karlsburg W rats—a new model of the metabolic syndrome , 2007, Pflügers Archiv - European Journal of Physiology.

[110]  J. Kral,et al.  Early-Life Stress and the Development of Obesity and Insulin Resistance in Juvenile Bonnet Macaques , 2007, Diabetes.

[111]  T. M. Lewin,et al.  Regulation of Triglyceride Metabolism. II. Function of mitochondrial GPAT1 in the regulation of triacylglycerol biosynthesis and insulin action. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[112]  K. Khunti,et al.  The role of physical activity in the management of impaired glucose tolerance: a systematic review , 2007, Diabetologia.

[113]  Philip Levy,et al.  Metabolic Syndrome: A Work in Progress, but a Useful Construct , 2007, Circulation.

[114]  V. Mohan,et al.  Serum visfatin in relation to visceral fat, obesity, and type 2 diabetes mellitus in Asian Indians. , 2007, Metabolism: clinical and experimental.

[115]  D. Richard,et al.  Effects of the CRF1 receptor antagonist SSR125543 on energy balance and food deprivation-induced neuronal activation in obese Zucker rats. , 2007, The Journal of endocrinology.

[116]  A. Saiki,et al.  Preheparin serum lipoprotein lipase mass might be a biomarker of metabolic syndrome. , 2007, Diabetes research and clinical practice.

[117]  A. Oguz,et al.  Prevalence of the metabolic syndrome among Turkish adults , 2007 .

[118]  B. Wajchenberg.  beta-cell failure in diabetes and preservation by clinical treatment. , 2007, Endocrine reviews.

[119]  Y. Matsuzawa,et al.  Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis , 2007, The Lancet.

[120]  Jeremy E. Davis,et al.  Soy Protein and Isoflavones Influence Adiposity and Development of Metabolic Syndrome in the Obese Male ZDF Rat , 2007, Annals of Nutrition and Metabolism.

[121]  W. R. Wikoff,et al.  Mobilization of pro-inflammatory lipids in obese Plscr3-deficient mice , 2007, Genome Biology.

[122]  T. Alexandrides,et al.  Resolution of Diabetes Mellitus and Metabolic Syndrome following Roux-en-Y Gastric Bypass and a Variant of Biliopancreatic Diversion in Patients with Morbid Obesity , 2007, Obesity surgery.

[123]  Deborah M. Brown,et al.  Unique Ability of Activated CD4+ T Cells but Not Rested Effectors to Migrate to Non-lymphoid Sites in the Absence of Inflammation* , 2007, Journal of Biological Chemistry.

[124]  Myoungsook Lee,et al.  Adiponectin represents an independent risk factor for hypertension in middle aged Korean women. , 2007, Asia Pacific journal of clinical nutrition.

[125]  Corby K. Martin,et al.  Effect of calorie restriction with or without exercise on body composition and fat distribution. , 2007, The Journal of clinical endocrinology and metabolism.

[126]  R. Bayoumi,et al.  Heritability of Determinants of the Metabolic Syndrome among Healthy Arabs of the Oman Family Study , 2007, Obesity.

[127]  E. M. Albuquerque,et al.  Opposite lipemic response of Wistar rats and C57BL/6 mice to dietary glucose or fructose supplementation. , 2007, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[128]  H. Kraemer,et al.  Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women: the A TO Z Weight Loss Study: a randomized trial. , 2007, JAMA.

[129]  C. Herder,et al.  Relationship between adipocyte size and adipokine expression and secretion. , 2007, The Journal of clinical endocrinology and metabolism.

[130]  S. Grundy,et al.  Harmonizing the definition of the metabolic syndrome: comparison of the criteria of the Adult Treatment Panel III and the International Diabetes Federation in United States American and European populations. , 2007, The American journal of cardiology.

[131]  D. Pfaff,et al.  Silencing of estrogen receptor α in the ventromedial nucleus of hypothalamus leads to metabolic syndrome , 2007, Proceedings of the National Academy of Sciences.

[132]  Richard S Legro,et al.  A 27-year-old woman with a diagnosis of polycystic ovary syndrome. , 2007, JAMA.

[133]  V. Mohan,et al.  Prevalence of metabolic syndrome using WHO, ATPIII and IDF definitions in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES‐34) , 2007, Diabetes/metabolism research and reviews.

[134]  B. Gümüş,et al.  Prevalence of metabolic syndrome and its association with erectile dysfunction among urologic patients: metabolic backgrounds of erectile dysfunction. , 2007, Urology.

[135]  J. Kaufman,et al.  Association between adult and childhood socioeconomic status and prevalence of the metabolic syndrome in African Americans: the Pitt County Study. , 2007, American journal of public health.

[136]  S. Fowler,et al.  The prevalence of retinopathy in impaired glucose tolerance and recent‐onset diabetes in the Diabetes Prevention Program , 2007, Diabetic medicine : a journal of the British Diabetic Association.

[137]  S. Proctor,et al.  Impaired postprandial apolipoprotein-B48 metabolism in the obese, insulin-resistant JCR:LA-cp rat: increased atherogenicity for the metabolic syndrome. , 2007, Atherosclerosis.

[138]  B. Caballero,et al.  An urban–rural comparison of the prevalence of the metabolic syndrome in Eastern China , 2007, Public Health Nutrition.

[139]  K. Choi,et al.  Serum adiponectin, interleukin-10 levels and inflammatory markers in the metabolic syndrome. , 2007, Diabetes research and clinical practice.

[140]  J. Viikari,et al.  The prevalence of the metabolic syndrome in young adults. The Cardiovascular Risk in Young Finns Study , 2007, Journal of internal medicine.

[141]  R. Eckel.  Mechanisms of the components of the metabolic syndrome that predispose to diabetes and atherosclerotic CVD , 2007, Proceedings of the Nutrition Society.

[142]  M. Górska,et al.  Increased serum interleukin-18 concentration is associated with hypoadiponectinemia in obesity, independently of insulin resistance , 2007, International Journal of Obesity.

[143]  N. Sonenberg,et al.  Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2. , 2007, The Journal of clinical investigation.

[144]  G. Norata,et al.  Plasma resistin levels correlate with determinants of the metabolic syndrome. , 2007, European journal of endocrinology.

[145]  N. Bukan,et al.  Decreased plasma adiponectin is associated with insulin resistance and HDL cholesterol in overweight subjects. , 2007, Endocrine journal.

[146]  N. Paynter,et al.  The effect of weight loss on C-reactive protein: a systematic review. , 2007, Archives of internal medicine.

[147]  S. Bonner-Weir,et al.  A dominant role for glucose in β cell compensation of insulin resistance , 2007 .

[148]  H. Aburatani,et al.  Glucokinase and IRS-2 are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance. , 2007, The Journal of clinical investigation.

[149]  V. Somers,et al.  Sleep and the metabolic syndrome , 2007, Experimental physiology.

[150]  A. Nicolosi,et al.  Features of metabolic syndrome in non‐diabetic Italians and Brazilians: a discriminant analysis , 2007, International journal of clinical practice.

[151]  W. Pories,et al.  The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus , 1997, Journal of Gastrointestinal Surgery.

[152]  M. Laakso,et al.  Cardiovascular disease risk factors as predictors of Type 2 (non-insulin-dependent) diabetes mellitus in elderly subjects , 1993, Diabetologia.

[153]  Benjamin J. Epstein,et al.  Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure , 2007 .

[154]  P. Arner,et al.  Adipose triglyceride lipase and hormone-sensitive lipase protein expression is decreased in the obese insulin-resistant state. , 2007, The Journal of clinical endocrinology and metabolism.

[155]  M. Martínez-Larrad,et al.  Endothelial nitric oxide synthase haplotypes are associated with features of metabolic syndrome. , 2007, Clinical chemistry.

[156]  J. Nunes.  The risk factor association syndrome as a barisystemic syndrome: a view on obesity and the metabolic syndrome. , 2007, Medical hypotheses.

[157]  J. Hokanson,et al.  Haplotypes in the lipoprotein lipase gene influence fasting insulin and discovery of a new risk haplotype. , 2007, The Journal of clinical endocrinology and metabolism.

[158]  S. Devaraj,et al.  Statins and biomarkers of inflammation , 2007, Current atherosclerosis reports.

[159]  K. Ge,et al.  Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China , 2007, International Journal of Obesity.

[160]  R. Zechner,et al.  Adipose Triglyceride Lipase and Hormone-sensitive Lipase Are the Major Enzymes in Adipose Tissue Triacylglycerol Catabolism* , 2006, Journal of Biological Chemistry.

[161]  J. Després,et al.  Abdominal obesity and metabolic syndrome , 2006, Nature.

[162]  S. Marcovina,et al.  Apolipoprotein A1 and B. , 2006, Clinics in laboratory medicine.

[163]  R. Korbut,et al.  Adipocytokines - novel link between inflammation and vascular function? , 2006, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[164]  S. Klein,et al.  Effect of lifestyle intervention on metabolic coronary heart disease risk factors in obese older adults. , 2006, The American journal of clinical nutrition.

[165]  Greta L. Hoetzer,et al.  Influence of Metabolic Syndrome on Biomarkers of Oxidative Stress and Inflammation in Obese Adults , 2006, Obesity.

[166]  I. Gause-Nilsson,et al.  Prevalence of metabolic syndrome in an elderly Swedish population , 2006, Acta Diabetologica.

[167]  B. Pedersen,et al.  Interleukin-6 Regulation of AMP-Activated Protein Kinase , 2006, Diabetes.

[168]  J. Manson,et al.  Low-carbohydrate-diet score and the risk of coronary heart disease in women. , 2006, The New England journal of medicine.

[169]  N. Christou,et al.  Impact of bariatric surgery on cardiovascular and musculoskeletal morbidity. , 2006, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[170]  Daniel B. Shin,et al.  Prevalence of cardiovascular risk factors in patients with psoriasis. , 2022, Central European journal of public health.

[171]  J. Schneider,et al.  ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome. , 2006, Cell metabolism.

[172]  D. Laflamme,et al.  Understanding and managing obesity in dogs and cats. , 2006, The Veterinary clinics of North America. Small animal practice.

[173]  S. Liatis,et al.  Sympathetic System Activity in Obesity and Metabolic Syndrome , 2006, Annals of the New York Academy of Sciences.

[174]  M. Ryan,et al.  Insulin Resistance and Obesity in a Mouse Model of Systemic Lupus Erythematosus , 2006, Hypertension.

[175]  I. Idris,et al.  Obstructive sleep apnoea is independently associated with the metabolic syndrome but not insulin resistance state , 2006, Cardiovascular diabetology.

[176]  J. L. San Millán,et al.  Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women. , 2006, Archives of internal medicine.

[177]  S. Yusuf,et al.  Effect of ramipril on the incidence of diabetes. , 2006, The New England journal of medicine.

[178]  Allen J. Taylor,et al.  The effect of 24 months of combination statin and extended-release niacin on carotid intima‐media thickness: ARBITER 3* , 2006, Current medical research and opinion.

[179]  B. Geloneze,et al.  Relationship between adipokines, inflammation, and vascular reactivity in lean controls and obese subjects with metabolic syndrome. , 2006, Clinics.

[180]  E. D. Jones,et al.  Examining the metabolic syndrome in Russia. , 2006, International journal of nursing practice.

[181]  M. Wolzt,et al.  The Adipokine Visfatin is Markedly Elevated in Obese Children , 2006, Journal of pediatric gastroenterology and nutrition.

[182]  K. Jin,et al.  Do health behaviors moderate the effect of socioeconomic status on metabolic syndrome? , 2006, Annals of epidemiology.

[183]  M. Laakso,et al.  Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial , 2006, The Lancet.

[184]  S. Grundy,et al.  Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study , 2006, The Lancet.

[185]  V. Mohan,et al.  Serum levels of interleukin 6, C-reactive protein, vascular cell adhesion molecule 1, and monocyte chemotactic protein 1 in relation to insulin resistance and glucose intolerance--the Chennai Urban Rural Epidemiology Study (CURES). , 2006, Metabolism: clinical and experimental.

[186]  M. Hoenig.  The cat as a model for human nutrition and disease , 2006, Current opinion in clinical nutrition and metabolic care.

[187]  B. Masserini,et al.  Reduced levels of adiponectin in sleep apnea syndrome , 2006, Journal of endocrinological investigation.

[188]  M. Kubo,et al.  Metabolic syndrome and CKD in a general Japanese population: the Hisayama Study. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[189]  R. Hegele,et al.  Genetic determinants of the metabolic syndrome , 2006, Nature Clinical Practice Cardiovascular Medicine.

[190]  F. Collins,et al.  Common Variants in Maturity-Onset Diabetes of the Young Genes Contribute to Risk of Type 2 Diabetes in Finns , 2006, Diabetes.

[191]  G. Ailhaud,et al.  Adipose tissue as a secretory organ: from adipogenesis to the metabolic syndrome. , 2006, Comptes rendus biologies.

[192]  R. Ahima.  Adipose Tissue as an Endocrine Organ , 2006, Obesity.

[193]  Ralph B D'Agostino,et al.  Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. , 2006, The Journal of clinical endocrinology and metabolism.

[194]  A. Goldfine,et al.  Inflammation and insulin resistance. , 2006, The Journal of clinical investigation.

[195]  C. Semenkovich.  Insulin resistance and atherosclerosis. , 2006, The Journal of clinical investigation.

[196]  Diego G. Silva,et al.  Fat aussie--a new Alström syndrome mouse showing a critical role for ALMS1 in obesity, diabetes, and spermatogenesis. , 2006, Molecular endocrinology.

[197]  N. Moustaid‐Moussa,et al.  The Adipose Renin-Angiotensin System Modulates Systemic Markers of Insulin Sensitivity and Activates the Intrarenal Renin-Angiotensin System , 2006, Journal of biomedicine & biotechnology.

[198]  G. Andrews,et al.  Relative androgen deficiency in relation to obesity and metabolic status in older men , 2006, Diabetes, obesity & metabolism.

[199]  F. Orio,et al.  Cardiovascular risk in women with polycystic ovary syndrome. , 2006, Fertility and sterility.

[200]  A. Doria,et al.  Heritability of serum resistin and its genetic correlation with insulin resistance-related features in nondiabetic Caucasians. , 2006, The Journal of clinical endocrinology and metabolism.

[201]  S. Díaz,et al.  Metabolic syndrome, insulin resistance and the inflammation markers C-reactive protein and ferritin , 2006, European Journal of Clinical Nutrition.

[202]  S. Raptis,et al.  Early vascular lesions in subjects with metabolic syndrome and prediabetes. , 2006, International angiology : a journal of the International Union of Angiology.

[203]  B. Nicklas,et al.  Aerobic Exercise Is Necessary to Improve Glucose Utilization with Moderate Weight Loss in Women , 2006, Obesity.

[204]  E. Ingelsson,et al.  Metabolic syndrome and risk for heart failure in middle-aged men , 2006, Heart.

[205]  B. Balkau,et al.  Practical way to assess metabolic syndrome using a continuous score obtained from principal components analysis , 2006, Diabetologia.

[206]  M. Pfeffer,et al.  AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. , 2006, Journal of the American College of Cardiology.

[207]  M. Pfeffer,et al.  AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. , 2006, Circulation.

[208]  B. Paulweber,et al.  Cholesteryl Ester Transfer Protein in Metabolic Syndrome , 2006, Obesity.

[209]  J. Shaw,et al.  Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[210]  G. Duncan.  Prevalence of diabetes and impaired fasting glucose levels among US adolescents: National Health and Nutrition Examination Survey, 1999-2002. , 2006, Archives of pediatrics & adolescent medicine.

[211]  R. McManus,et al.  Genetic and nutrient determinants of the metabolic syndrome , 2006, Current opinion in cardiology.

[212]  J. Shaw,et al.  Point: Impaired Fasting Glucose: The Case for the New American Diabetes Association Criterion , 2006, Diabetes Care.

[213]  J. Ménard,et al.  Mice chronically fed a westernized experimental diet as a model of obesity, metabolic syndrome and osteoporosis , 2006, European journal of nutrition.

[214]  N. Petrovsky,et al.  Adaptive failure to high-fat diet characterizes steatohepatitis in Alms1 mutant mice. , 2006, Biochemical and biophysical research communications.

[215]  M. Quon,et al.  Reciprocal Relationships Between Insulin Resistance and Endothelial Dysfunction: Molecular and Pathophysiological Mechanisms , 2006, Circulation.

[216]  G. Lewis,et al.  Differential effects of monounsaturated, polyunsaturated and saturated fat ingestion on glucose-stimulated insulin secretion, sensitivity and clearance in overweight and obese, non-diabetic humans , 2006, Diabetologia.

[217]  H. Alberti,et al.  The metabolic syndrome in an Arab population: a first look at the new International Diabetes Federation criteria , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[218]  T. Demir.  Prevalence of erectile dysfunction in patients with metabolic syndrome , 2006, International journal of urology : official journal of the Japanese Urological Association.

[219]  H. K. Lee,et al.  A rural-urban comparison of the characteristics of the metabolic syndrome by gender in Korea: The Korean Health and Genome Study (KHGS) , 2006, Journal of endocrinological investigation.

[220]  Hua Cheng,et al.  [Relationship between serum interleukin-10 and insulin resistance in metabolic syndrome]. , 2006, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

[221]  B. Freedman,et al.  Genetic determinants of the metabolic syndrome , 2006, Current hypertension reports.

[222]  P. Nilsson,et al.  The metabolic syndrome: a glance at its history , 2006, Journal of hypertension.

[223]  B. Zinman,et al.  Characteristics and prevalence of the metabolic syndrome among three ethnic groups in Canada , 2006, International Journal of Obesity.

[224]  S. Grundy.  Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy , 2006, Nature Reviews Drug Discovery.

[225]  S. Grundy,et al.  Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. , 2006, Journal of the American College of Cardiology.

[226]  S. Haffner,et al.  Geographic variations of the International Diabetes Federation and the National Cholesterol Education Program-Adult Treatment Panel III definitions of the metabolic syndrome in nondiabetic subjects. , 2006, Diabetes care.

[227]  G. Pacini.  The hyperbolic equilibrium between insulin sensitivity and secretion. , 2006, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[228]  M. Suter,et al.  Changes in Body Composition, Metabolic Profile and Nutritional Status 24 Months after Gastric Banding , 2006, Obesity surgery.

[229]  M. Blüher,et al.  The polygenetically inherited metabolic syndrome of WOKW rats is associated with insulin resistance and altered gene expression in adipose tissue , 2006, Diabetes/metabolism research and reviews.

[230]  L. Khaodhiar,et al.  Pharmacological and surgical treatments for obesity. , 2006, American heart journal.

[231]  Trevor A. Mori,et al.  The independent effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans , 2006, Current opinion in clinical nutrition and metabolic care.

[232]  L. Lind,et al.  Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality : prospective , population based cohort study , 2006 .

[233]  F Xavier Pi-Sunyer,et al.  Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. , 2006, JAMA.

[234]  C. Corless,et al.  The metabolic syndrome resulting from a knockout of the NEIL1 DNA glycosylase. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[235]  David V. Power,et al.  Standards of Medical Care in Diabetes: Response to position statement of the American Diabetes Association , 2006 .

[236]  N. Clark,et al.  Standards of Medical Care in Diabetes: Response to Power , 2006 .

[237]  Hong Wang,et al.  Serum Adiponectin Levels in Adult Male Patients with Obstructive Sleep Apnea Hypopnea Syndrome , 2006, Respiration.

[238]  F. Kronenberg,et al.  Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1,727 healthy Caucasians. , 2006, Diabetes.

[239]  B. Balkau,et al.  Weight change and changes in the metabolic syndrome as the French population moves towards overweight: the D.E.S.I.R. cohort. , 2006, International journal of epidemiology.

[240]  M. Low,et al.  Glucocorticoids exacerbate obesity and insulin resistance in neuron-specific proopiomelanocortin-deficient mice. , 2006, The Journal of clinical investigation.

[241]  Frank M. Sacks,et al.  Dietary Approaches to Prevent and Treat Hypertension: A Scientific Statement From the American Heart Association , 2006, Hypertension.

[242]  J. Ruige,et al.  Among inflammation and coagulation markers, PAI-1 is a true component of the metabolic syndrome , 2006, International Journal of Obesity.

[243]  E. Kékes,et al.  Prevalence of metabolic syndrome estimated by International Diabetes Federation criteria in a Hungarian population , 2006, Blood pressure.

[244]  A. Madan,et al.  Metabolic syndrome: yet another co-morbidity gastric bypass helps cure. , 2005, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[245]  R. Krauss,et al.  Intercorrelations among plasma high density lipoprotein, obesity and triglycerides in a normal population , 1980, Lipids.

[246]  Hafiz M. R. Khan,et al.  Metabolic syndrome in aboriginal Canadians: prevalence and genetic associations. , 2006, Atherosclerosis.

[247]  C. Katsanos.  Prescribing Aerobic Exercise for the Regulation of Postprandial Lipid Metabolism , 2006, Sports medicine.

[248]  Tetsuji Sato,et al.  The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. , 2006, Annals of internal medicine.

[249]  J. Sassard.  [Human essential hypertension and genetic hypertension in rats: the Lyon model]. , 2006, Bulletin de l'Academie nationale de medecine.

[250]  S. Summers,et al.  Ceramides in insulin resistance and lipotoxicity. , 2006, Progress in lipid research.

[251]  Chien-Jen Chen,et al.  Prevalence of obesity and metabolic syndrome in Taiwan. , 2006, Journal of the Formosan Medical Association = Taiwan yi zhi.

[252]  G. Reaven,et al.  The fourth Musketeer — from Alexandre Dumas to Claude Bernard , 2006, Diabetologia.

[253]  L. Kuller,et al.  Metabolic syndrome: risk factor distribution and 18-year mortality in the multiple risk factor intervention trial. , 2006, Diabetes care.

[254]  J. Zicha,et al.  Apolipoprotein A5 and hypertriglyceridemia in Prague hypertriglyceridemic rats. , 2006, Physiological research.

[255]  G. Heiss,et al.  The effect of conjugated equine oestrogen on diabetes incidence: the Women’s Health Initiative randomised trial , 2006, Diabetologia.

[256]  A. Karter,et al.  Prediction of Type 2 Diabetes Mellitus With Alternative Definitions of the Metabolic Syndrome: The Insulin Resistance Atherosclerosis Study , 2005, Circulation.

[257]  Richard W Morris,et al.  Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. , 2005, Archives of internal medicine.

[258]  M. Quon,et al.  Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions. , 2005, Journal of the American College of Cardiology.

[259]  B. Neuschwander‐Tetri.  Nonalcoholic steatohepatitis and the metabolic syndrome. , 2005, The American journal of the medical sciences.

[260]  D. Schneider.  Abnormalities of coagulation, platelet function, and fibrinolysis associated with syndromes of insulin resistance , 2005, Coronary artery disease.

[261]  Chien-Ning Huang,et al.  Association of interleukin-10 A-592C and T-819C polymorphisms with type 2 diabetes mellitus. , 2005, Human immunology.

[262]  G. Reaven.  Insulin resistance, the insulin resistance syndrome, and cardiovascular disease. , 2005, Panminerva medica.

[263]  K. Reynolds,et al.  Epidemiology of the Metabolic Syndrome , 2005, The American journal of the medical sciences.

[264]  F. Azizi,et al.  Beneficial effects of a Dietary Approaches to Stop Hypertension eating plan on features of the metabolic syndrome. , 2005, Diabetes care.

[265]  R. D'Agostino,et al.  Metabolic Syndrome as a Precursor of Cardiovascular Disease and Type 2 Diabetes Mellitus , 2005, Circulation.

[266]  J. Kampert,et al.  Association of muscular strength with incidence of metabolic syndrome in men. , 2005, Medicine and science in sports and exercise.

[267]  S. Grundy.  Metabolic syndrome scientific statement by the American Heart Association and the National Heart, Lung, and Blood Institute. , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[268]  E. Ford,et al.  Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. , 2005, Diabetes care.

[269]  A. Vidal-Puig,et al.  Mouse models of PPAR-γ deficiency: dissecting PPAR-γ's role in metabolic homoeostasis , 2005 .

[270]  Fernando Costa,et al.  Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. , 2005, Circulation.

[271]  R. Krauss,et al.  Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. , 2005, Cardiology in review.

[272]  D. Pereg,et al.  Normal fasting plasma glucose levels and type 2 diabetes in young men. , 2005, The New England journal of medicine.

[273]  J. Duarte,et al.  A diet supplemented with husks of Plantago ovata reduces the development of endothelial dysfunction, hypertension, and obesity by affecting adiponectin and TNF-alpha in obese Zucker rats. , 2005, The Journal of nutrition.

[274]  A. Krasinskas,et al.  Surgically-Induced Weight Loss Significantly Improves Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome , 2005, Annals of surgery.

[275]  E. Mignot,et al.  A link between short sleep and obesity: building the evidence for causation. , 2005, Sleep.

[276]  M. Fasshauer,et al.  Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. , 2005, Diabetes.

[277]  Paul Zimmet,et al.  The metabolic syndrome—a new worldwide definition , 2005, The Lancet.

[278]  J. O’Keefe,et al.  Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials. , 2005, Journal of the American College of Cardiology.

[279]  S. Blair,et al.  Revised Adult Treatment Panel III Guidelines and Cardiovascular Disease Mortality in Men Attending a Preventive Medical Clinic , 2005, Circulation.

[280]  Richard Kahn,et al.  The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. , 2005, Diabetes care.

[281]  Sara Rosenbaum,et al.  Recent National Cholesterol Education Program Adult Treatment Panel III update: adjustments and options. , 2005, The American journal of cardiology.

[282]  S. Murray,et al.  Alms1-disrupted mice recapitulate human Alström syndrome. , 2005, Human molecular genetics.

[283]  L. Bouter,et al.  Metabolic Syndrome and 10-Year Cardiovascular Disease Risk in the Hoorn Study , 2005, Circulation.

[284]  M. Matsuda,et al.  Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. , 2005, Science.

[285]  K. Taylor,et al.  The 3' untranslated region of the lipoprotein lipase gene: haplotype structure and association with post-heparin plasma lipase activity. , 2005, The Journal of clinical endocrinology and metabolism.

[286]  J. Shaw,et al.  Mainstreaming the metabolic syndrome: a definitive definition , 2005, The Medical journal of Australia.

[287]  Z. Tran,et al.  Aerobic exercise, lipids and lipoproteins in overweight and obese adults: a meta-analysis of randomized controlled trials , 2005, International Journal of Obesity.

[288]  H. Wyatt,et al.  HIGHLIGHTED TOPIC Role of Exercise in Reducing the Risk of Diabetes and Obesity Role of physical activity in preventing and treating obesity , 2005 .

[289]  J. Horowitz,et al.  Alterations in carbohydrate metabolism in response to short-term dietary carbohydrate restriction. , 2005, American journal of physiology. Endocrinology and metabolism.

[290]  G. Mancia,et al.  Obstructive Sleep Apnea–Dependent and –Independent Adrenergic Activation in Obesity , 2005, Hypertension.

[291]  J. Kampert,et al.  Cardiorespiratory Fitness Is Inversely Associated With the Incidence of Metabolic Syndrome: A Prospective Study of Men and Women , 2005, Circulation.

[292]  L. Tavazzi,et al.  Metabolic syndrome and risk of cardiovascular events after myocardial infarction. , 2005, Journal of the American College of Cardiology.

[293]  T. Hansen,et al.  The prevalence of the metabolic syndrome in a danish population of women with previous gestational diabetes mellitus is three-fold higher than in the general population. , 2005, The Journal of clinical endocrinology and metabolism.

[294]  J. Holloszy.  Exercise-induced increase in muscle insulin sensitivity. , 2005, Journal of applied physiology.

[295]  S. Soegondo.  Atherogenic dyslipidemia and the metabolic syndrome. , 2005, Acta medica Indonesiana.

[296]  G. Chertow,et al.  Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. , 2005, Journal of the American Society of Nephrology : JASN.

[297]  L. Goodyear,et al.  Contraction signaling to glucose transport in skeletal muscle. , 2005, Journal of applied physiology.

[298]  D. Rader,et al.  New Insights Into the Regulation of HDL Metabolism and Reverse Cholesterol Transport , 2005, Circulation research.

[299]  Z. Bloomgarden.  Second World Congress on the Insulin Resistance Syndrome: insulin resistance syndrome and nonalcoholic fatty liver disease. , 2005, Diabetes care.

[300]  G. Marchesini,et al.  Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity. , 2005, The Journal of clinical endocrinology and metabolism.

[301]  D. Lackland,et al.  Addressing the Global Cardiovascular Risk of Hypertension, Dyslipidemia, Diabetes Mellitus, and the Metabolic Syndrome in the Southeastern United States, Part II: Treatment Recommendations for Management of the Global Cardiovascular Risk of Hypertension, Dyslipidemia, Diabetes Mellitus, and the Meta , 2005, The American journal of the medical sciences.

[302]  E. Bixler,et al.  Sleep apnea is a manifestation of the metabolic syndrome. , 2005, Sleep medicine reviews.

[303]  J. Beilby,et al.  Elevated Interleukin-18 Levels Are Associated With the Metabolic Syndrome Independent of Obesity and Insulin Resistance , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[304]  G. Reaven.  The metabolic syndrome: requiescat in pace. , 2005, Clinical chemistry.

[305]  J. Jessurun,et al.  Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. , 2005, The Journal of clinical investigation.

[306]  H. Ginsberg,et al.  Regulation of plasma triglycerides in insulin resistance and diabetes. , 2005, Archives of medical research.

[307]  C. Kahn,et al.  Effects of diet and genetic background on sterol regulatory element-binding protein-1c, stearoyl-CoA desaturase 1, and the development of the metabolic syndrome. , 2005, Diabetes.

[308]  U. Ekelund,et al.  Physical activity energy expenditure predicts progression toward the metabolic syndrome independently of aerobic fitness in middle-aged healthy Caucasians: the Medical Research Council Ely Study. , 2005, Diabetes care.

[309]  Youngkyu Park,et al.  A Dominant Negative Peroxisome Proliferator-activated Receptor-γ Knock-in Mouse Exhibits Features of the Metabolic Syndrome* , 2005, Journal of Biological Chemistry.

[310]  S. Fowler,et al.  The Effect of Metformin and Intensive Lifestyle Intervention on the Metabolic Syndrome: The Diabetes Prevention Program Randomized Trial , 2005, Annals of Internal Medicine.

[311]  Jing Chen,et al.  Prevalence of the metabolic syndrome and overweight among adults in China , 2005, The Lancet.

[312]  R. Eckel,et al.  Insulin sensitivity determines the effectiveness of dietary macronutrient composition on weight loss in obese women. , 2005, Obesity research.

[313]  J. Tuomilehto,et al.  Educational inequalities in the metabolic syndrome and coronary heart disease among middle-aged men and women. , 2005, International journal of epidemiology.

[314]  S. Fowler,et al.  Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program. , 2005, Diabetes care.

[315]  S. Fowler,et al.  Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program. , 2005, Diabetes.

[316]  E. Lakatta,et al.  The metabolic syndrome in older individuals: prevalence and prediction of cardiovascular events: the Cardiovascular Health Study. , 2005, Diabetes care.

[317]  A. Aljada,et al.  Contemporary Reviews in Cardiovascular Medicine Metabolic Syndrome A Comprehensive Perspective Based on Interactions Between Obesity, Diabetes, and Inflammation , 2022 .

[318]  K. Matthews,et al.  Hormone therapy, lipoprotein subclasses, and coronary calcification: the Healthy Women Study. , 2005, Archives of internal medicine.

[319]  H. Kohl,et al.  Sedentary behavior, physical activity, and the metabolic syndrome among U.S. adults. , 2005, Obesity research.

[320]  G. Dagenais,et al.  Low-Density Lipoprotein Subfractions and the Long-Term Risk of Ischemic Heart Disease in Men: 13-Year Follow-Up Data From the Québec Cardiovascular Study , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[321]  M. Izquierdo,et al.  Twice-weekly progressive resistance training decreases abdominal fat and improves insulin sensitivity in older men with type 2 diabetes. , 2005, Diabetes care.

[322]  David M Maahs,et al.  Low Plasma Adiponectin Levels Predict Progression of Coronary Artery Calcification , 2005, Circulation.

[323]  A. Erbay,et al.  High prevalence of metabolic syndrome among young women with premature coronary artery disease , 2005, Coronary artery disease.

[324]  Maria Inês Schmidt,et al.  The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. , 2005, Diabetes care.

[325]  R. Fagard,et al.  Effect of resistance training on resting blood pressure: a meta-analysis of randomized controlled trials , 2005, Journal of hypertension.

[326]  J. Griffith,et al.  Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. , 2005, JAMA.

[327]  W. März,et al.  Prevalence of the Metabolic Syndrome in Southwest Germany , 2005, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[328]  D. Coleman.  Effects of parabiosis of obese with diabetes and normal mice , 1973, Diabetologia.

[329]  Y. Murata,et al.  Cholesterol feeding prevents adiposity in the obese female aromatase knockout (ArKO) mouse. , 2005, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[330]  R. Nesto,et al.  Incidence of metabolic syndrome and insulin resistance in a population with organic erectile dysfunction. , 2005, The journal of sexual medicine.

[331]  D. Lawlor,et al.  Does the new International Diabetes Federation definition of the metabolic syndrome predict CHD any more strongly than older definitions? Findings from the British Women’s Heart and Health Study , 2005, Diabetologia.

[332]  Claude Bouchard,et al.  Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. , 2004, The New England journal of medicine.

[333]  Catherine B. Chan,et al.  Free Fatty Acid-induced β-Cell Defects Are Dependent on Uncoupling Protein 2 Expression* , 2004, Journal of Biological Chemistry.

[334]  Betsy L Cadwell,et al.  Trends in the prevalence and ratio of diagnosed to undiagnosed diabetes according to obesity levels in the U.S. , 2004, Diabetes care.

[335]  M. Herregods,et al.  Weight Loss-Associated Induction of Peroxisome Proliferator-Activated Receptor-&agr; and Peroxisome Proliferator–Activated Receptor-&ggr; Correlate With Reduced Atherosclerosis and Improved Cardiovascular Function in Obese Insulin-Resistant Mice , 2004, Circulation.

[336]  R. Eckel,et al.  The metabolic syndrome and inflammation. , 2004, Metabolic syndrome and related disorders.

[337]  J. Mustonen,et al.  Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy. , 2004, The New England journal of medicine.

[338]  S. Haffner,et al.  Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? , 2004, Diabetes care.

[339]  B. Hansen,et al.  Age-related changes in metabolic parameters of nonhuman primates. , 2004, The journals of gerontology. Series A, Biological sciences and medical sciences.

[340]  I. Perry,et al.  Prevalence and lifestyle determinants of the metabolic syndrome. , 2004, Irish medical journal.

[341]  K. Borch-Johnsen,et al.  Prevalence of the metabolic syndrome among the Inuit in Greenland. A comparison between two proposed definitions , 2004, Diabetic medicine : a journal of the British Diabetic Association.

[342]  A. Mainous,et al.  Race, Rural Residence, and Control of Diabetes and Hypertension , 2004, The Annals of Family Medicine.

[343]  A. Biggeri,et al.  Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study. , 2004, Diabetes care.

[344]  H. Jacob,et al.  Mapping the Genetic Determinants of Hypertension, Metabolic Diseases, and Related Phenotypes in the Lyon Hypertensive Rat , 2004, Hypertension.

[345]  C. Ahn,et al.  Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults. , 2004, Archives of internal medicine.

[346]  K. Gauvreau,et al.  Prevalence of the Metabolic Syndrome in American Adolescents: Findings From the Third National Health and Nutrition Examination Survey , 2004, Circulation.

[347]  L. Glimcher,et al.  Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes , 2004, Science.

[348]  Henry Buchwald,et al.  Bariatric surgery: a systematic review and meta-analysis. , 2004, JAMA.

[349]  Wei-Jei Lee,et al.  Effects of obesity surgery on the metabolic syndrome. , 2004, Archives of surgery.

[350]  Ali H Mokdad,et al.  Increasing prevalence of the metabolic syndrome among u.s. Adults. , 2004, Diabetes care.

[351]  R. Marfella,et al.  Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. , 2004, JAMA.

[352]  A. Aljada,et al.  Circulating Mononuclear Cells in the Obese Are in a Proinflammatory State , 2004, Circulation.

[353]  S. Yusuf,et al.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.

[354]  A. Hevener,et al.  Adiposity, dyslipidemia, and insulin resistance in mice with targeted deletion of phospholipid scramblase 3 (PLSCR3). , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[355]  Ken Williams,et al.  National Cholesterol Education Program Versus World Health Organization Metabolic Syndrome in Relation to All-Cause and Cardiovascular Mortality in the San Antonio Heart Study , 2004, Circulation.

[356]  Nathan D. Wong,et al.  Impact of the Metabolic Syndrome on Mortality From Coronary Heart Disease, Cardiovascular Disease, and All Causes in United States Adults , 2004, Circulation.

[357]  P. Wilson,et al.  Estimating cardiovascular disease risk and the metabolic syndrome: a Framingham view. , 2004, Endocrinology and metabolism clinics of North America.

[358]  J. Paolini,et al.  Simvastatin Does Not Have a Clinically Significant Pharmacokinetic Interaction With Fenofibrate in Humans , 2004, Journal of clinical pharmacology.

[359]  I. S. Wood,et al.  Adipokines: inflammation and the pleiotropic role of white adipose tissue , 2004, British Journal of Nutrition.

[360]  R. Ross,et al.  Interindividual variation in abdominal subcutaneous and visceral adipose tissue: influence of measurement site. , 2004, Journal of applied physiology.

[361]  Steven B Heymsfield,et al.  Metabolic syndrome in normal-weight Americans: new definition of the metabolically obese, normal-weight individual. , 2004, Diabetes care.

[362]  T. Valle,et al.  Prevalence of the metabolic syndrome and its components: findings from a Finnish general population sample and the Diabetes Prevention Study cohort. , 2004, Diabetes care.

[363]  M. Laville,et al.  Suppressor of cytokine signaling 3 expression and insulin resistance in skeletal muscle of obese and type 2 diabetic patients. , 2004, Diabetes.

[364]  R. Nesto.  C‐reactive protein, its role in inflammation, Type 2 diabetes and cardiovascular disease, and the effects of insulin‐sensitizing treatment with thiazolidinediones , 2004, Diabetic medicine : a journal of the British Diabetic Association.

[365]  F. Orio,et al.  The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study. , 2004, The Journal of clinical endocrinology and metabolism.

[366]  Judith Wylie-Rosett,et al.  Weight management through lifestyle modification for the prevention and management of type 2 diabetes: rationale and strategies: a statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition. , 2004, Diabetes care.

[367]  D. Rader,et al.  The triglyceride-high-density lipoprotein axis: an important target of therapy? , 2004, American heart journal.

[368]  W. Buurman,et al.  Macrophage inhibitory factor, plasminogen activator inhibitor-1, other acute phase proteins, and inflammatory mediators normalize as a result of weight loss in morbidly obese subjects treated with gastric restrictive surgery. , 2004, The Journal of clinical endocrinology and metabolism.

[369]  A. Sanyal,et al.  Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease. , 2004, Clinics in liver disease.

[370]  Jane B Shofer,et al.  Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. , 2004, Diabetes.

[371]  L. Fernández-Salazar,et al.  Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis. , 2004, Diabetes care.

[372]  D. Befroy,et al.  Mechanism of Hepatic Insulin Resistance in Non-alcoholic Fatty Liver Disease* , 2004, Journal of Biological Chemistry.

[373]  M. Rutter,et al.  C-Reactive Protein, the Metabolic Syndrome, and Prediction of Cardiovascular Events in the Framingham Offspring Study , 2004, Circulation.

[374]  L. Simons,et al.  Effects of ezetimibe added to on-going statin therapy on the lipid profile of hypercholesterolemic patients with diabetes mellitus or metabolic syndrome , 2004, Current medical research and opinion.

[375]  B. Pedersen,et al.  AMPK activity is diminished in tissues of IL-6 knockout mice: the effect of exercise. , 2004, Biochemical and biophysical research communications.

[376]  Neil J Stone,et al.  Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines , 2004, Circulation.

[377]  R. Bergman,et al.  Identification of Quantitative Trait Loci for Glucose Homeostasis The Insulin Resistance Atherosclerosis Study (IRAS) Family Study , 2022 .

[378]  J. Staffa,et al.  Rhabdomyolysis with HMG‐CoA reductase inhibitors and gemfibrozil combination therapy , 2004, Pharmacoepidemiology and drug safety.

[379]  B. Howard,et al.  Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women’s Health Initiative Hormone Trial , 2004, Diabetologia.

[380]  Arvind Shah,et al.  Reduction of cardiovascular events by simvastatin in nondiabetic coronary heart disease patients with and without the metabolic syndrome: subgroup analyses of the Scandinavian Simvastatin Survival Study (4S). , 2004, Diabetes care.

[381]  H. Mulder,et al.  Biochemical Mechanism of Lipid-induced Impairment of Glucose-stimulated Insulin Secretion and Reversal with a Malate Analogue* , 2004, Journal of Biological Chemistry.

[382]  K. Flegal,et al.  Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. , 2004, JAMA.

[383]  J. Davignon.  Beneficial Cardiovascular Pleiotropic Effects of Statins , 2004, Circulation.

[384]  Dong Zhao,et al.  Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. , 2004, JAMA.

[385]  C. Ballantyne,et al.  Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restriction. , 2004, The Journal of clinical endocrinology and metabolism.

[386]  M. Bajaj,et al.  Type 2 diabetes in South Asians: A pathophysiologic focus on the Asian-Indian epidemic , 2004, Current diabetes reports.

[387]  A. Garg,et al.  Lipodystrophies: rare disorders causing metabolic syndrome. , 2004, Endocrinology and metabolism clinics of North America.

[388]  Yuko Oguma,et al.  Physical activity decreases cardiovascular disease risk in women: review and meta-analysis. , 2004, American journal of preventive medicine.

[389]  P. Scherer,et al.  The delicate balance between fat and muscle: adipokines in metabolic disease and musculoskeletal inflammation. , 2004, Current opinion in pharmacology.

[390]  J. Shaw,et al.  The metabolic syndrome: prevalence in worldwide populations. , 2004, Endocrinology and metabolism clinics of North America.

[391]  J. Flier,et al.  Adipose Tissue as an Endocrine Organ , 2014 .

[392]  P. Wilson,et al.  Using metabolic syndrome traits for efficient detection of impaired glucose tolerance. , 2004, Diabetes care.

[393]  J. Tuomilehto,et al.  Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. , 2004, Archives of internal medicine.

[394]  W. Yancy,et al.  A Low-Carbohydrate, Ketogenic Diet versus a Low-Fat Diet To Treat Obesity and Hyperlipidemia , 2004, Annals of Internal Medicine.

[395]  E. Gracely,et al.  The Effects of Low-Carbohydrate versus Conventional Weight Loss Diets in Severely Obese Adults: One-Year Follow-up of a Randomized Trial , 2004, Annals of Internal Medicine.

[396]  J. Seckl,et al.  Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[397]  R. Ross,et al.  Exercise-induced reduction in obesity and insulin resistance in women: a randomized controlled trial. , 2004, Obesity research.

[398]  V. Somers,et al.  Obstructive sleep apnoea, metabolic syndrome, and cardiovascular outcomes. , 2004, European heart journal.

[399]  I. Kowalska,et al.  Relationship between insulin sensitivity and sphingomyelin signaling pathway in human skeletal muscle. , 2004, Diabetes.

[400]  Cynthia J. Girman,et al.  Plasma adiponectin levels and risk of myocardial infarction in men. , 2004, JAMA.

[401]  G. Marchesini,et al.  WHO and ATPIII proposals for the definition of the metabolic syndrome in patients with Type 2 diabetes , 2004, Diabetic medicine : a journal of the British Diabetic Association.

[402]  G. Reaven.  Insulin resistance, cardiovascular disease, and the metabolic syndrome: how well do the emperor's clothes fit? , 2004, Diabetes care.

[403]  S. Hadjadj,et al.  Adiponectin gene polymorphisms and adiponectin levels are independently associated with the development of hyperglycemia during a 3-year period: the epidemiologic data on the insulin resistance syndrome prospective study. , 2004, Diabetes.

[404]  A. Garg.  Acquired and inherited lipodystrophies. , 2004, The New England journal of medicine.

[405]  J. Zicha,et al.  Rat model of familial combined hyperlipidemia as a result of comparative mapping. , 2004, Physiological genomics.

[406]  U. Smith,et al.  High local concentrations and effects on differentiation implicate interleukin-6 as a paracrine regulator. , 2004, Obesity research.

[407]  S. Reis,et al.  Clinical Importance of Obesity Versus the Metabolic Syndrome in Cardiovascular Risk in Women: A Report From the Women’s Ischemia Syndrome Evaluation (WISE) Study , 2004, Circulation.

[408]  K. Petersen,et al.  Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. , 2004, The New England journal of medicine.

[409]  S. Grundy,et al.  Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[410]  L. Rudel,et al.  Associations of low density lipoprotein particle composition with atherogenicity. , 2004 .

[411]  A. Greenberg,et al.  Adipocytokines and insulin resistance. , 2004, The Journal of clinical endocrinology and metabolism.

[412]  R. Leach,et al.  The obesity epidemic, metabolic syndrome and future prevention strategies , 2004, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[413]  J. Seufert,et al.  Leptin Effects on Pancreatic β-Cell Gene Expression and Function , 2004 .

[414]  P. Wilson,et al.  Carbohydrate nutrition, insulin resistance, and the prevalence of the metabolic syndrome in the Framingham Offspring Cohort. , 2004, Diabetes care.

[415]  Claude Lenfant,et al.  Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[416]  A. Gotto,et al.  The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). , 2004, The American journal of cardiology.

[417]  C. Nishida,et al.  Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies , 2004, The Lancet.

[418]  Anthony Gamst,et al.  Association of the Metabolic Syndrome With History of Myocardial Infarction and Stroke in the Third National Health and Nutrition Examination Survey , 2004, Circulation.

[419]  J. Panza,et al.  Enhanced Vascular Activity of Endogenous Endothelin-1 in Obese Hypertensive Patients , 2004 .

[420]  E. Bonora,et al.  The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study , 2004, Diabetic medicine : a journal of the British Diabetic Association.

[421]  M. Cooper,et al.  Diabetic renal disease: from recent studies to improved clinical practice , 2004, Diabetic medicine : a journal of the British Diabetic Association.

[422]  F. Io,et al.  SMXA-5 Mouse as a Diabetic Model Susceptible to Feeding a High-fat Diet , 2004, Bioscience, biotechnology, and biochemistry.

[423]  S. Kihara,et al.  Adiponectin and Metabolic Syndrome , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[424]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[425]  C. Aguilar-Salinas,et al.  High prevalence of metabolic syndrome in Mexico. , 2004, Archives of medical research.

[426]  J. Colwell.  Antiplatelet Agents for the Prevention of Cardiovascular Disease in Diabetes Mellitus , 2004, American journal of cardiovascular drugs : drugs, devices, and other interventions.

[427]  D. Panagiotakos,et al.  Impact of lifestyle habits on the prevalence of the metabolic syndrome among Greek adults from the ATTICA study. , 2004, American heart journal.

[428]  R. Hanson,et al.  Polymorphisms in candidate genes for type 2 diabetes mellitus in a Mexican population with metabolic syndrome findings. , 2004, Diabetes research and clinical practice.

[429]  A. Sherwood,et al.  Effects of Exercise, Diet and Weight Loss on High Blood Pressure , 2004, Sports medicine.

[430]  M. Miura,et al.  A transgenic mouse model for monitoring endoplasmic reticulum stress , 2004, Nature Medicine.

[431]  K. Taylor,et al.  Lipoprotein lipase is a gene for insulin resistance in Mexican Americans. , 2004, Diabetes.

[432]  B. Saltin,et al.  Searching for the exercise factor: is IL-6 a candidate? , 2004, Journal of Muscle Research & Cell Motility.

[433]  M. Goran,et al.  The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity. , 2004, The Journal of clinical endocrinology and metabolism.

[434]  L. Sjöström,et al.  XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. , 2004, Diabetes care.

[435]  K. Wellen,et al.  Obesity-induced inflammatory changes in adipose tissue. , 2003, The Journal of clinical investigation.

[436]  M. Desai,et al.  Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.

[437]  L. Tartaglia,et al.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.

[438]  V. Fonseca.  Effect of thiazolidinediones on body weight in patients with diabetes mellitus. , 2003, The American journal of medicine.

[439]  S. M. Setter,et al.  Metformin hydrochloride in the treatment of type 2 diabetes mellitus: a clinical review with a focus on dual therapy. , 2003, Clinical therapeutics.

[440]  A. Aljada,et al.  Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. , 2003, Diabetes.

[441]  Daniel W. Jones,et al.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.

[442]  P. Froguel,et al.  Dual roles of adiponectin/Acrp30 in vivo as an anti-diabetic and anti-atherogenic adipokine. , 2003, Current drug targets. Immune, endocrine and metabolic disorders.

[443]  Tracey McLaughlin,et al.  Use of Metabolic Markers To Identify Overweight Individuals Who Are Insulin Resistant , 2003, Annals of Internal Medicine.

[444]  D. Juurlink,et al.  The safety of over-the-counter niacin. A randomized placebo-controlled trial [ISRCTN18054903] , 2003, BMC clinical pharmacology.

[445]  Wei Chen,et al.  Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa Heart Study. , 2003, JAMA.

[446]  S. Haffner,et al.  The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. , 2003, Diabetes care.

[447]  J. Sowers.  Recommendations for special populations: diabetes mellitus and the metabolic syndrome. , 2003, American journal of hypertension.

[448]  R. Unger.  Lipid overload and overflow: metabolic trauma and the metabolic syndrome , 2003, Trends in Endocrinology & Metabolism.

[449]  B. Balkau,et al.  The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. study. , 2003, Diabetes & metabolism.

[450]  B. Zinman,et al.  Identification of subjects with insulin resistance and beta-cell dysfunction using alternative definitions of the metabolic syndrome. , 2003, Diabetes.

[451]  J. Pankow,et al.  Linkage analysis of a composite factor for the multiple metabolic syndrome: the National Heart, Lung, and Blood Institute Family Heart Study. , 2003, Diabetes.

[452]  B. Courten,et al.  Higher prevalence of type 2 diabetes, metabolic syndrome and cardiovascular diseases in gypsies than in non-gypsies in Slovakia. , 2003, Diabetes research and clinical practice.

[453]  J. Eisen,et al.  Comparative studies of resistin expression and phylogenomics in human and mouse. , 2003, Biochemical and biophysical research communications.

[454]  P. Amouyel,et al.  The Gly16-->Arg16 and Gln27-->Glu27 polymorphisms of beta2-adrenergic receptor are associated with metabolic syndrome in men. , 2003, The Journal of clinical endocrinology and metabolism.

[455]  Richard Hellman,et al.  American College of Endocrinology position statement on the insulin resistance syndrome. , 2003, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[456]  F. Sacks,et al.  Clinical review 163: Cardiovascular endocrinology: Low-density lipoprotein size and cardiovascular disease: a reappraisal. , 2003, The Journal of clinical endocrinology and metabolism.

[457]  M. McGovern,et al.  Once-daily niacin extended release/lovastatin combination tablet has more favorable effects on lipoprotein particle size and subclass distribution than atorvastatin and simvastatin. , 2003, Preventive cardiology.

[458]  R. Hegele.  Monogenic forms of insulin resistance: apertures that expose the common metabolic syndrome , 2003, Trends in Endocrinology & Metabolism.

[459]  F. Katsukawa,et al.  Ethnic differences in abdominal visceral fat accumulation between Japanese, African-Americans, and Caucasians: a meta-analysis , 2003, Acta Diabetologica.

[460]  B. Corkey,et al.  Fatty acid metabolism and insulin secretion in pancreatic beta cells , 2003, Diabetologia.

[461]  L. Chuang,et al.  National surveillance for type 2 diabetes mellitus in Taiwanese children. , 2003, JAMA.

[462]  J. Shaw,et al.  Preventing Type 2 diabetes and the dysmetabolic syndrome in the real world: a realistic view , 2003, Diabetic medicine : a journal of the British Diabetic Association.

[463]  W. Dietz,et al.  Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. , 2003, Archives of pediatrics & adolescent medicine.

[464]  L. Niskanen,et al.  Sedentary lifestyle, poor cardiorespiratory fitness, and the metabolic syndrome. , 2003, Medicine and science in sports and exercise.

[465]  R. D'Agostino,et al.  Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. , 2003, Diabetes.

[466]  P. Macfarlane,et al.  Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study , 2003, Circulation.

[467]  Markolf Hanefeld,et al.  Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. , 2003, JAMA.

[468]  Ihab Hajjar,et al.  Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. , 2003, JAMA.

[469]  M. Quon,et al.  Molecular and physiologic actions of insulin related to production of nitric oxide in vascular endothelium , 2003, Current diabetes reports.

[470]  F. Azizi,et al.  Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. , 2003, Diabetes research and clinical practice.

[471]  P. Vollenweider,et al.  Clustering of cardiovascular risk factors mimicking the human metabolic syndrome X in eNOS null mice. , 2003, Swiss medical weekly.

[472]  Fernando Costa,et al.  Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Ph , 2003, Circulation.

[473]  D. Capuzzi,et al.  Effects of extended-release niacin on lipoprotein subclass distribution. , 2003, The American journal of cardiology.

[474]  Jeanne M Clark,et al.  Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis. , 2003, JAMA.

[475]  G. Reaven,et al.  Insulin resistance/compensatory hyperinsulinemia, essential hypertension, and cardiovascular disease. , 2003, The Journal of clinical endocrinology and metabolism.

[476]  B. Egan.  Insulin resistance and the sympathetic nervous system , 2003, Current hypertension reports.

[477]  J. Krieger,et al.  Obesity-associated activation of angiotensin and endothelin in the cardiovascular system. , 2003, The international journal of biochemistry & cell biology.

[478]  A. Oberg,et al.  Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome. , 2003, The Journal of clinical endocrinology and metabolism.

[479]  M. C. Carr,et al.  The emergence of the metabolic syndrome with menopause. , 2003, The Journal of clinical endocrinology and metabolism.

[480]  H. Tunstall-Pedoe,et al.  Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. , 2003, European heart journal.

[481]  M. Low,et al.  Lack of Proopiomelanocortin Peptides Results in Obesity and Defective Adrenal Function but Normal Melanocyte Pigmentation in the Murine C57BL/6 Genetic Background , 2003, Annals of the New York Academy of Sciences.

[482]  J. Fernández-Real,et al.  Insulin resistance and chronic cardiovascular inflammatory syndrome. , 2003, Endocrine reviews.

[483]  D. Rader,et al.  A randomized trial of a low-carbohydrate diet for obesity. , 2003, The New England journal of medicine.

[484]  E. Gracely,et al.  A low-carbohydrate as compared with a low-fat diet in severe obesity. , 2003, The New England journal of medicine.

[485]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[486]  Douglas L. Rothman,et al.  Mitochondrial Dysfunction in the Elderly: Possible Role in Insulin Resistance , 2003, Science.

[487]  G. Assmann,et al.  Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders. , 2003, Atherosclerosis.

[488]  B. Neuschwander‐Tetri,et al.  Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference , 2003, Hepatology.

[489]  S. Lévesque,et al.  Incidence and clinical characteristics of the metabolic syndrome in patients with coronary artery disease , 2003, Coronary artery disease.

[490]  Anoop Misra,et al.  Clinical and pathophysiological consequences of abdominal adiposity and abdominal adipose tissue depots. , 2003, Nutrition.

[491]  Z. Bloomgarden,et al.  Inflammation and insulin resistance. , 2003, Diabetes care.

[492]  S. Teutsch,et al.  NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. , 2003, Diabetes.

[493]  Avron Spiro,et al.  Are metabolic risk factors one unified syndrome? Modeling the structure of the metabolic syndrome X. , 2003, American journal of epidemiology.

[494]  P. Morange,et al.  Weak and non‐independent association between plasma TAFI antigen levels and the insulin resistance syndrome , 2003, Journal of thrombosis and haemostasis : JTH.

[495]  S. Daniels,et al.  A randomized trial comparing a very low carbohydrate diet and a calorie-restricted low fat diet on body weight and cardiovascular risk factors in healthy women. , 2003, The Journal of clinical endocrinology and metabolism.

[496]  D. Stengel,et al.  Increased Low-Density Lipoprotein Oxidation and Impaired High-Density Lipoprotein Antioxidant Defense Are Associated With Increased Macrophage Homing and Atherosclerosis in Dyslipidemic Obese Mice: LCAT Gene Transfer Decreases Atherosclerosis , 2003, Circulation.

[497]  Y. Murata,et al.  Cellular and molecular characterization of the adipose phenotype of the aromatase-deficient mouse. , 2003, Endocrinology.

[498]  R. Dobrowsky,et al.  A Role for Ceramide, but Not Diacylglycerol, in the Antagonism of Insulin Signal Transduction by Saturated Fatty Acids* , 2003, The Journal of Biological Chemistry.

[499]  I. Saito,et al.  Association of body mass index, body fat, and weight gain with inflammation markers among rural residents in Japan. , 2003, Circulation journal : official journal of the Japanese Circulation Society.

[500]  A. Hinney,et al.  Hyperphagia, not hypometabolism, causes early onset obesity in melanocortin-4 receptor knockout mice. , 2003, Physiological genomics.

[501]  D. Hunninghake,et al.  A dose‐ranging study of a new, once‐daily, dual‐component drug product containing niacin extended‐release and lovastatin , 2003, Clinical cardiology.

[502]  P. Verdecchia,et al.  Association Between Periodontal Disease and Left Ventricle Mass in Essential Hypertension , 2003, Hypertension.

[503]  E. Ford,et al.  A comparison of the prevalence of the metabolic syndrome using two proposed definitions. , 2003, Diabetes care.

[504]  B. Howard,et al.  Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic american indians: the Strong Heart Study. , 2003, Diabetes care.

[505]  Shankuan Zhu,et al.  The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. , 2003, Archives of internal medicine.

[506]  R. Eckel,et al.  Obesity: Mechanisms and Clinical Management , 2003 .

[507]  K. Rowley,et al.  Association of albuminuria and the metabolic syndrome , 2003, Current diabetes reports.

[508]  R. Parker,et al.  Role of the fatty acid binding protein mal1 in obesity and insulin resistance. , 2003, Diabetes.

[509]  A. Jenkins,et al.  Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. , 2003, Diabetes.

[510]  Nancy R Cook,et al.  C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events: An 8-Year Follow-Up of 14 719 Initially Healthy American Women , 2003, Circulation.

[511]  Gary L Myers,et al.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. , 2003, Circulation.

[512]  H. Boeing,et al.  Adiponectin and protection against type 2 diabetes mellitus , 2003, The Lancet.

[513]  Lawrence J Appel,et al.  Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[514]  Y. Minokoshi,et al.  Role of AMP-activated protein kinase in leptin-induced fatty acid oxidation in muscle. , 2001, Biochemical Society transactions.

[515]  J. Chan,et al.  High prevalence of insulin resistance and metabolic syndrome in overweight/obese preadolescent Hong Kong Chinese children aged 9-12 years. , 2003, Diabetes care.

[516]  J. Dietschy,et al.  The intestinal absorption of biliary and dietary cholesterol as a drug target for lowering the plasma cholesterol level. , 2003, Preventive cardiology.

[517]  C. Duante,et al.  Prevalence of metabolic syndrome among Filipino adults aged 20 years and over. , 2003, Asia Pacific journal of clinical nutrition.

[518]  M. Cnop,et al.  The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat. , 2003, Diabetes.

[519]  D. Cook,et al.  Metabolic syndrome and renal sodium handling in three ethnic groups living in England , 2003, Diabetologia.

[520]  S. Grundy,et al.  Diet composition and the metabolic syndrome: what is the optimal fat intake? , 2002, The American journal of medicine.

[521]  J. Mckenney,et al.  National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2002 .

[522]  R. Brolin,et al.  Bariatric surgery and long-term control of morbid obesity. , 2002, JAMA.

[523]  Jukka T Salonen,et al.  The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. , 2002, JAMA.

[524]  A. Onat,et al.  Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels--a prospective and cross-sectional evaluation. , 2002, Atherosclerosis.

[525]  P. Schauer,et al.  Medical and surgical options in the treatment of severe obesity. , 2002, American journal of surgery.

[526]  L. Niskanen,et al.  Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. , 2002, American journal of epidemiology.

[527]  R. Bergman,et al.  Insulin resistance and associated compensatory responses in african-american and Hispanic children. , 2002, Diabetes care.

[528]  A. Simopoulos.  Omega-3 Fatty Acids in Inflammation and Autoimmune Diseases , 2002, Journal of the American College of Nutrition.

[529]  O. Pedersen,et al.  Association studies between microsatellite markers within the gene encoding human 11beta-hydroxysteroid dehydrogenase type 1 and body mass index, waist to hip ratio, and glucocorticoid metabolism. , 2002, The Journal of clinical endocrinology and metabolism.

[530]  P. Kwiterovich.  Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity. , 2002, The American journal of cardiology.

[531]  F. Kraemer,et al.  Hormone-sensitive Lipase: Control of Intracellular Tri-(di-)acylglycerol and Cholesteryl Ester Hydrolysis Structural and Biochemical Properties Thematic Review , 2022 .

[532]  Robert L Hanson,et al.  Components of the "metabolic syndrome" and incidence of type 2 diabetes. , 2002, Diabetes.

[533]  Ronald Klein,et al.  Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. , 2002, Diabetes care.

[534]  Jing He,et al.  Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. , 2002, Diabetes.

[535]  Catherine Kim,et al.  Gestational diabetes and the incidence of type 2 diabetes: a systematic review. , 2002, Diabetes care.

[536]  Moyses Szklo,et al.  Risk factor groupings related to insulin resistance and their synergistic effects on subclinical atherosclerosis: the atherosclerosis risk in communities study. , 2002, Diabetes.

[537]  Ralph B D'Agostino,et al.  Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. , 2002, Archives of internal medicine.

[538]  G. Shulman,et al.  Fatty Acid Infusion Selectively Impairs Insulin Action on Akt1 and Protein Kinase C λ/ζ but Not on Glycogen Synthase Kinase-3* , 2002, The Journal of Biological Chemistry.

[539]  J. Manson,et al.  Walking compared with vigorous exercise for the prevention of cardiovascular events in women. , 2002, The New England journal of medicine.

[540]  E. Ford.  Does Exercise Reduce Inflammation? Physical Activity and C-Reactive Protein Among U.S. Adults , 2002, Epidemiology.

[541]  M. Charles,et al.  Extended-release niacin treatment of the atherogenic lipid profile and lipoprotein(a) in diabetes. , 2002, Metabolism: clinical and experimental.

[542]  T. Buchanan,et al.  Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. , 2002, Diabetes.

[543]  F. Foufelle,et al.  New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c. , 2002, The Biochemical journal.

[544]  R. Krauss,et al.  Metabolic origins and clinical significance of LDL heterogeneity DOI 10.1194/jlr.R200004-JLR200 , 2002, Journal of Lipid Research.

[545]  J. Rood,et al.  Effects of diets enriched in saturated (palmitic), monounsaturated (oleic), or trans (elaidic) fatty acids on insulin sensitivity and substrate oxidation in healthy adults. , 2002, Diabetes care.

[546]  P. Savage,et al.  Factor analysis of metabolic syndrome using directly measured insulin sensitivity: The Insulin Resistance Atherosclerosis Study. , 2002, Diabetes.

[547]  B. Ainsworth,et al.  Cardiorespiratory Fitness and C-Reactive Protein Among a Tri-Ethnic Sample of Women , 2002, Circulation.

[548]  S. Grundy,et al.  Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial. , 2002, Archives of internal medicine.

[549]  P. Whelton,et al.  Dietary sodium intake and incidence of congestive heart failure in overweight US men and women: first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. , 2002, Archives of internal medicine.

[550]  James F Sallis,et al.  AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. , 2002, Circulation.

[551]  M. Charles,et al.  Niacin treatment of the atherogenic lipid profile and Lp(a) in diabetes , 2002, Diabetes, obesity & metabolism.

[552]  B. Vohr,et al.  Insulin resistance syndrome in women with prior history of gestational diabetes mellitus. , 2002, The Journal of clinical endocrinology and metabolism.

[553]  S. Franceschi,et al.  Glycemic index: overview of implications in health and disease. , 2002, The American journal of clinical nutrition.

[554]  M. Laakso,et al.  Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial , 2002, The Lancet.

[555]  G. Shulman,et al.  Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and β‐cell dysfunction , 2002, European journal of clinical investigation.

[556]  Rainer Rauramaa,et al.  Low levels of leisure-time physical activity and cardiorespiratory fitness predict development of the metabolic syndrome. , 2002, Diabetes care.

[557]  R. Muniyappa,et al.  Pleiotropic Effects of Statins: Lipid Reduction and Beyond , 2002 .

[558]  W. Tamborlane,et al.  Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. , 2002, The New England journal of medicine.

[559]  E. van Cauter,et al.  Sleep-disordered breathing and the current epidemic of obesity: consequence or contributing factor? , 2002, American journal of respiratory and critical care medicine.

[560]  J. Sorkin,et al.  Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. , 2002, American journal of respiratory and critical care medicine.

[561]  M. McGovern,et al.  Long-term safety and efficacy of a once-daily niacin/lovastatin formulation for patients with dyslipidemia. , 2002, The American journal of cardiology.

[562]  R. Ross,et al.  Effects of an energy-restrictive diet with or without exercise on abdominal fat, intermuscular fat, and metabolic risk factors in obese women. , 2002, Diabetes care.

[563]  K. Lam,et al.  Obstructive sleep apnea is independently associated with insulin resistance. , 2002, American journal of respiratory and critical care medicine.

[564]  S. Fowler,et al.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002 .

[565]  R. Bergman,et al.  Accurate Assessment of β-Cell Function: The Hyperbolic Correction , 2002 .

[566]  G. Assmann,et al.  Simple Scoring Scheme for Calculating the Risk of Acute Coronary Events Based on the 10-Year Follow-Up of the Prospective Cardiovascular Münster (PROCAM) Study , 2002, Circulation.

[567]  W. Dietz,et al.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. , 2002, JAMA.

[568]  I. G. Fantus,et al.  Hepatic Very Low Density Lipoprotein-ApoB Overproduction Is Associated with Attenuated Hepatic Insulin Signaling and Overexpression of Protein-tyrosine Phosphatase 1B in a Fructose-fed Hamster Model of Insulin Resistance* , 2002, The Journal of Biological Chemistry.

[569]  J. Russell,et al.  Animal models of insulin resistance and cardiovascular disease: some therapeutic approaches using the JCR:LA‐cp rat , 2002, Diabetes, obesity & metabolism.

[570]  J. McGarry.  Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. , 2002, Diabetes.

[571]  C. Ohlsson,et al.  Interleukin-6-deficient mice develop mature-onset obesity , 2002, Nature Medicine.

[572]  R. Wing,et al.  Successful weight loss maintenance. , 2003, Annual review of nutrition.

[573]  B. Fielding,et al.  Substituting dietary saturated fat with polyunsaturated fat changes abdominal fat distribution and improves insulin sensitivity , 2002, Diabetologia.

[574]  C. Ballantyne,et al.  Influence of Low High-Density Lipoprotein Cholesterol and Elevated Triglyceride on Coronary Heart Disease Events and Response to Simvastatin Therapy in 4S , 2001, Circulation.

[575]  L. Rossetti,et al.  Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. , 2001, The Journal of clinical investigation.

[576]  J. Shaw,et al.  Global and societal implications of the diabetes epidemic , 2001, Nature.

[577]  J. Flier,et al.  A Transgenic Model of Visceral Obesity and the Metabolic Syndrome , 2001, Science.

[578]  J. Dawson,et al.  Carotid Intimal-Medial Thickness Is Related to Cardiovascular Risk Factors Measured From Childhood Through Middle Age: The Muscatine Study , 2001, Circulation.

[579]  G. de Simone,et al.  Benefits of sustained moderate weight loss in obesity. , 2001, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[580]  S. Julius,et al.  Antihypertensive treatment of patients with diabetes and hypertension. , 2001, American journal of hypertension.

[581]  F Vinicor,et al.  The continuing epidemics of obesity and diabetes in the United States. , 2001, JAMA.

[582]  A. Genazzani,et al.  Prospective evaluation of body weight and body fat distribution in early postmenopausal women with and without hormonal replacement therapy. , 2001, Maturitas.

[583]  L. Groop,et al.  The dysmetabolic syndrome , 2001, Journal of internal medicine.

[584]  J. Manson,et al.  C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. , 2001, JAMA.

[585]  J. Kooner,et al.  C-Reactive Protein, Insulin Resistance, Central Obesity, and Coronary Heart Disease Risk in Indian Asians From the United Kingdom Compared With European Whites , 2001, Circulation.

[586]  B. Egan,et al.  Insulin resistance and cardiovascular disease. , 2001, American journal of hypertension.

[587]  Anthony G. Johnson,et al.  Blood pressure is linked to salt intake and modulated by the angiotensinogen gene in normotensive and hypertensive elderly subjects , 2001, Journal of hypertension.

[588]  R. Cone,et al.  Melanocortin-4 receptor is required for acute homeostatic responses to increased dietary fat , 2001, Nature Neuroscience.

[589]  S. Rhee,et al.  Saturated Fatty Acids, but Not Unsaturated Fatty Acids, Induce the Expression of Cyclooxygenase-2 Mediated through Toll-like Receptor 4* , 2001, The Journal of Biological Chemistry.

[590]  T. Valle,et al.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.

[591]  O. Resta,et al.  Sleep-related breathing disorders, loud snoring and excessive daytime sleepiness in obese subjects , 2001, International Journal of Obesity.

[592]  J M Dekker,et al.  Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study. , 2001, JAMA.

[593]  S. Grundy,et al.  Effect of Hydroxymethyl Glutaryl Coenzyme A Reductase Inhibitor Therapy on High Sensitive C-Reactive Protein Levels , 2001, Circulation.

[594]  L. Groop,et al.  Cardiovascular morbidity and mortality associated with the metabolic syndrome. , 2001, Diabetes care.

[595]  L. Landsberg.  Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why) , 2001, Journal of hypertension.

[596]  H. Pijl,et al.  Dietary fat content alters insulin-mediated glucose metabolism in healthy men. , 2001, The American journal of clinical nutrition.

[597]  B. M. Rasmussen,et al.  Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU study , 2001, Diabetologia.

[598]  D. Barbier.  [Depression in the elderly. Clinical aspects]. , 2001, Presse medicale.

[599]  R. Schwartz,et al.  Obesity, body fat distribution, insulin sensitivity and Islet beta-cell function as explanations for metabolic diversity. , 2001, The Journal of nutrition.

[600]  R. Krauss,et al.  Lipoprotein Candidate Genes for Multivariate Factors of the Insulin Resistance Syndrome: A Sib-pair Linkage Analysis in Women Twins , 2001, Twin Research.

[601]  Xiao Man Yang,et al.  Physiological increase in plasma leptin markedly inhibits insulin secretion in vivo. , 2001, Diabetes.

[602]  E. Bjertness,et al.  The metabolic syndrome in the West Bank population: an urban-rural comparison. , 2001, Diabetes care.

[603]  M. Lazar,et al.  The hormone resistin links obesity to diabetes , 2001, Nature.

[604]  S. Deeb,et al.  Hepatic Lipase as a Focal Point for the Development and Treatment of Coronary Artery Disease , 2001, Journal of Investigative Medicine.

[605]  A. Aljada,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society The Suppressive Effect of Dietary Restriction and Weight Loss in the Obese on the Generation of Reactive Oxygen Species by Leukocytes, Lipid Per , 2022 .

[606]  R. Knopp.  Evaluating niacin in its various forms. , 2000, The American journal of cardiology.

[607]  H. Rubins.  Triglycerides and Coronary Heart Disease: Implications of Recent Clinical Trials , 2000, Journal of cardiovascular risk.

[608]  B. Balkau.  The DECODE study. Diabetes epidemiology: collaborative analysis of diagnostic criteria in Europe. , 2000, Diabetes & metabolism.

[609]  O. Ezaki,et al.  Effect of dietary Platycodon grandiflorum on the improvement of insulin resistance in obese Zucker rats. , 2000, The Journal of nutritional biochemistry.

[610]  Robert Ross,et al.  Reduction in Obesity and Related Comorbid Conditions after Diet-Induced Weight Loss or Exercise-Induced Weight Loss in Men , 2000, Annals of Internal Medicine.

[611]  I. Shimomura,et al.  Leptin, troglitazone, and the expression of sterol regulatory element binding proteins in liver and pancreatic islets. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[612]  D. Gaudet,et al.  Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? , 2000, Circulation.

[613]  T. Wascher,et al.  Vascular dysfunction and myocardial contractility in the JCR:LA-corpulent rat. , 2000, Cardiovascular research.

[614]  A. Goldberg,et al.  Multiple-dose efficacy and safety of an extended-release form of niacin in the management of hyperlipidemia. , 2000, The American journal of cardiology.

[615]  Steven Blair,et al.  Low Cardiorespiratory Fitness and Physical Inactivity as Predictors of Mortality in Men with Type 2 Diabetes , 2000, Annals of Internal Medicine.

[616]  F. Horio,et al.  Characterization of hyperinsulinemic recombinant inbred (RI) strains (SMXA-5 and SMXA-9) derived from normoinsulinemic SM/J and A/J mice. , 2000, Experimental animals.

[617]  J. Tooke,et al.  Adverse endothelial function and the insulin resistance syndrome , 2000, Journal of internal medicine.

[618]  P. Kovacs,et al.  Genetic dissection of the syndrome X in the rat. , 2000, Biochemical and biophysical research communications.

[619]  Ortlepp,et al.  A metabolic syndrome of hypertension, hyperinsulinaemia and hypercholesterolaemia in the New Zealand obese mouse , 2000, European journal of clinical investigation.

[620]  P Weber,et al.  Triglyceride-lowering effect of omega-3 LC-polyunsaturated fatty acids--a review. , 2000, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[621]  C. Kahn,et al.  Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. , 2000, The Journal of clinical investigation.

[622]  M. Laakso,et al.  Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[623]  G. Shulman,et al.  On Diabetes: Insulin Resistance Cellular Mechanisms of Insulin Resistance , 2022 .

[624]  E. Feskens,et al.  The Relation between Blood Pressure and Mortality Due to Coronary Heart Disease among Men in Different Parts of the World , 2000 .

[625]  河村 智一.  Association of β3-adrenergic receptor gene polymorphism with insulin resistance in Japanese-American men , 2000 .

[626]  Orton,et al.  EFFECTS ON BLOOD PRESSURE OF REDUCED DIETARY SODIUM AND THE DIETARY APPROACHES TO STOP HYPERTENSION ( DASH ) DIET , 2000 .

[627]  M. Meydani.  Omega-3 fatty acids alter soluble markers of endothelial function in coronary heart disease patients. , 2000, Nutrition reviews.

[628]  J. F. Morton,et al.  Food sources of added sweeteners in the diets of Americans. , 2000, Journal of the American Dietetic Association.

[629]  P. Whelton,et al.  Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults. , 1999, JAMA.

[630]  K. Schenck-Gustafsson,et al.  Education and the metabolic syndrome in women. , 1999, Diabetes care.

[631]  H. Hauner,et al.  The Role of TNF-α in Human Adipose Tissue: Prevention of Weight Gain at the Expense of Insulin Resistance? , 1999, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[632]  I. Shimomura,et al.  Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[633]  P. Björntorp,et al.  Hypothalamic Origin of the Metabolic Syndrome X , 1999, Annals of the New York Academy of Sciences.

[634]  T. Wilt,et al.  Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. , 1999, The New England journal of medicine.

[635]  M. Jensen,et al.  Regional postprandial fatty acid metabolism in different obesity phenotypes. , 1999, Diabetes.

[636]  B. Gower,et al.  Visceral fat, insulin sensitivity, and lipids in prepubertal children. , 1999, Diabetes.

[637]  H. Lebovitz,et al.  Type 2 diabetes: an overview. , 1999, Clinical chemistry.

[638]  M. de Lorgeril,et al.  Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. , 1999, Circulation.

[639]  J. Russell,et al.  Cardiac myofibrillar and sarcoplasmic reticulum function are not depressed in insulin-resistant JCR:LA- cp rats. , 1999, American journal of physiology. Heart and circulatory physiology.

[640]  T. Moritani,et al.  The association between Trp64Arg polymorphism of the beta3-adrenergic receptor and autonomic nervous system activity. , 1999, The Journal of clinical endocrinology and metabolism.

[641]  B. Balkau,et al.  Comment on the provisional report from the WHO consultation , 1999, Diabetic medicine : a journal of the British Diabetic Association.

[642]  J. Hokanson,et al.  Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density. , 1999, Circulation.

[643]  C. Ballantyne,et al.  Correlation of serum triglyceride and its reduction by omega-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteins. , 1999, Atherosclerosis.

[644]  R. Troiano,et al.  Overweight prevalence among youth in the United States: Why so many different numbers? , 1999, International Journal of Obesity.

[645]  T. Fujii,et al.  Role of insulin resistance in the genesis of sodium sensitivity in essential hypertension , 1999, Journal of Human Hypertension.

[646]  A. Berg,et al.  Influence of mild to moderately elevated triglycerides on low density lipoprotein subfraction concentration and composition in healthy men with low high density lipoprotein cholesterol levels. , 1999, Atherosclerosis.

[647]  C. Arbeeny,et al.  Bile acid sequestrants: their use in combination with other lipid-lowering agents. , 1999, IDrugs : the investigational drugs journal.

[648]  L. Appel,et al.  Effects of dietary patterns on blood pressure: subgroup analysis of the Dietary Approaches to Stop Hypertension (DASH) randomized clinical trial. , 1999, Archives of internal medicine.

[649]  C. Kahn,et al.  Tissue-Specific Knockout of the Insulin Receptor in Pancreatic β Cells Creates an Insulin Secretory Defect Similar to that in Type 2 Diabetes , 1999, Cell.

[650]  E Moser,et al.  Rapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in humans. , 1999, Diabetes.

[651]  D L Rothman,et al.  Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. , 1999, The Journal of clinical investigation.

[652]  R. Ross,et al.  Atherosclerosis is an inflammatory disease. , 1998, American heart journal.

[653]  M. Cavaghan,et al.  Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. , 1999, Diabetes care.

[654]  W. Dodson,et al.  Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. , 1999, The Journal of clinical endocrinology and metabolism.

[655]  P. J. Randle,et al.  Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. , 1998, Diabetes/metabolism reviews.

[656]  V. Large,et al.  Regulation of lipolysis in humans. Pathophysiological modulation in obesity, diabetes, and hyperlipidaemia. , 1998, Diabetes & metabolism.

[657]  C. Kahn,et al.  A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. , 1998, Molecular cell.

[658]  L. Groop,et al.  The putative role of the hormone-sensitive lipase gene in the pathogenesis of Type II diabetes mellitus and abdominal obesity , 1998, Diabetologia.

[659]  Philip D. Harvey,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.

[660]  R. Holman,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. , 1998 .

[661]  W L Haskell,et al.  Effects of diet and exercise in men and postmenopausal women with low levels of HDL cholesterol and high levels of LDL cholesterol. , 1998, The New England journal of medicine.

[662]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[663]  G. Dagenais,et al.  Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. , 1998, JAMA.

[664]  R. Tracy,et al.  Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. , 1998, The New England journal of medicine.

[665]  A. Gotto,et al.  Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. , 1998, JAMA.

[666]  P. Arner.  Not all fat is alike , 1998, The Lancet.

[667]  B. Gower,et al.  Fat distribution and insulin response in prepubertal African American and white children. , 1998, The American journal of clinical nutrition.

[668]  D. Chisholm,et al.  The metabolically obese, normal-weight individual revisited. , 1998, Diabetes.

[669]  C. Packard,et al.  Associations of indices of adiposity with atherogenic lipoprotein subfractions , 1998, International Journal of Obesity.

[670]  P. Whelton,et al.  Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group. , 1998, JAMA.

[671]  R N Bergman,et al.  Intensity and amount of physical activity in relation to insulin sensitivity: the Insulin Resistance Atherosclerosis Study. , 1998, JAMA.

[672]  S. Grundy.  Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome. , 1998, The American journal of cardiology.

[673]  U. Beisiegel,et al.  Does Gastric Restriction Surgery Reduce the Risks of Metabolic Diseases? , 1998, Obesity surgery.

[674]  H. Okamura,et al.  Interleukin-18: a novel cytokine that augments both innate and acquired immunity. , 1998, Advances in immunology.

[675]  D. Hegsted.  Dietary fat intake and the risk of coronary heart disease in women. , 1998, The New England journal of medicine.

[676]  M. Carroll,et al.  Overweight and obesity in the United States: prevalence and trends, 1960–1994 , 1998, International Journal of Obesity.

[677]  J. Kampert,et al.  Reduction in cardiovascular disease risk factors: 6-month results from Project Active. , 1997, Preventive medicine.

[678]  V. Fuster,et al.  Aspirin as a therapeutic agent in cardiovascular disease: a statement for healthcare professionals from the American Heart Association. , 1997, Circulation.

[679]  Isabel R Schlaepfer,et al.  Prevention of diet-induced obesity in transgenic mice overexpressing skeletal muscle lipoprotein lipase. , 1997, The American journal of physiology.

[680]  J. Janosky,et al.  Insulin secretion and sensitivity in black versus white prepubertal healthy children. , 1997, The Journal of clinical endocrinology and metabolism.

[681]  S. Lillioja,et al.  Skeletal Muscle Triglyceride Levels Are Inversely Related to Insulin Action , 1997, Diabetes.

[682]  P. Whelton,et al.  Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. , 1997, JAMA.

[683]  D. Papanicolaou,et al.  Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. , 1997, The Journal of clinical endocrinology and metabolism.

[684]  R. Bain,et al.  Predictors of Progression From Impaired Glucose Tolerance to NIDDM: An Analysis of Six Prospective Studies , 1997, Diabetes.

[685]  L. V. Van Gaal,et al.  The beneficial effects of modest weight loss on cardiovascular risk factors. , 1997, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[686]  M. Kjaer,et al.  The effect of moderate exercise on postprandial glucose homeostasis in NIDDM patients , 1997, Diabetologia.

[687]  R. Cone,et al.  Targeted Disruption of the Melanocortin-4 Receptor Results in Obesity in Mice , 1997, Cell.

[688]  G. Dagenais,et al.  Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study. , 1997, Circulation.

[689]  W. Harris,et al.  n-3 fatty acids and serum lipoproteins: human studies. , 1997, The American journal of clinical nutrition.

[690]  E. V. van Puijenbroek,et al.  Possible increased risk of rhabdomyolysis during concomitant use of simvastatin and gemfibrozil , 1996, Journal of internal medicine.

[691]  M. Uusitupa,et al.  The effects of monounsaturated-fat enriched diet and polyunsaturated-fat enriched diet on lipid and glucose metabolism in subjects with impaired glucose tolerance. , 1996, European journal of clinical nutrition.

[692]  D. Chisholm,et al.  Abdominal Fat and Insulin Resistance in Normal and Overweight Women: Direct Measurements Reveal a Strong Relationship in Subjects at Both Low and High Risk of NIDDM , 1996, Diabetes.

[693]  A. Goldberg,et al.  Distinct effects of aerobic exercise training and weight loss on glucose homeostasis in obese sedentary men. , 1996, Journal of applied physiology.

[694]  G. Lewis,et al.  Acute Effects of Insulin in the Control of VLDL Production in Humans: Implications for the insulin-resistant state , 1996, Diabetes Care.

[695]  B. Thompson,et al.  Coronary risk factors measured in childhood and young adult life are associated with coronary artery calcification in young adults: the Muscatine Study. , 1996, Journal of the American College of Cardiology.

[696]  C. Packard,et al.  LDL subfractions and atherogenicity: an hypothesis from the University of Glasgow. , 1996, Current medical research and opinion.

[697]  P. Macfarlane,et al.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia , 1995 .

[698]  G. Franceschini,et al.  Triglycerides are major determinants of cholesterol esterification/transfer and HDL remodeling in human plasma. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[699]  W. Pories,et al.  Who Would Have Thought It? An Operation Proves to Be the Most Effective Therapy for Adult‐Onset Diabetes Mellitus , 1995, Annals of surgery.

[700]  L. Groop,et al.  Association of a polymorphism in the beta 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. , 1995, The New England journal of medicine.

[701]  A. Vollmer,et al.  Pressor effects of portal venous oleate infusion. A proposed mechanism for obesity hypertension. , 1995, Hypertension.

[702]  H. Nakano,et al.  [Obesity in the elderly]. , 1995, Nihon rinsho. Japanese journal of clinical medicine.

[703]  R. Eckel,et al.  Alterations in lipoprotein lipase in insulin resistance. , 1995, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[704]  B. Spiegelman,et al.  Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. , 1995, The Journal of clinical investigation.

[705]  R. Krauss,et al.  Dense low density lipoproteins and coronary artery disease. , 1995, The American journal of cardiology.

[706]  G. Lewis,et al.  Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. , 1995, The Journal of clinical investigation.

[707]  M. Taskinen,et al.  The insulin resistance syndrome in smokers is related to smoking habits. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[708]  J. H. Johnson,et al.  Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[709]  E. Ravussin,et al.  Effects of a Traditional Lifestyle on Obesity in Pima Indians , 1994, Diabetes Care.

[710]  N. Fineberg,et al.  Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. , 1994, The Journal of clinical investigation.

[711]  M. Uusitupa,et al.  Effects of two high-fat diets with different fatty acid compositions on glucose and lipid metabolism in healthy young women. , 1994, The American journal of clinical nutrition.

[712]  L. Rossetti,et al.  Mechanisms of fatty acid-induced inhibition of glucose uptake. , 1994, The Journal of clinical investigation.

[713]  J. D. Proctor,et al.  A comparison of the efficacy and toxic effects of sustained- vs immediate-release niacin in hypercholesterolemic patients. , 1994, JAMA.

[714]  M D Jensen,et al.  In vivo regulation of lipolysis in humans. , 1994, Journal of lipid research.

[715]  P. Barter,et al.  Effect of pravastatin and omega-3 fatty acids on plasma lipids and lipoproteins in patients with combined hyperlipidemia. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[716]  E. Newsholme,et al.  Effects of saturated and polyunsaturated fat enriched diet on the skeletal muscle insulin sensitivity in young rats. , 1993, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[717]  R. Wing,et al.  Relative effects of calorie restriction and weight loss in noninsulin-dependent diabetes mellitus. , 1993, The Journal of clinical endocrinology and metabolism.

[718]  C. Quesenberry,et al.  Usual Dietary Fat Intake and Insulin Concentrations in Healthy Women Twins , 1993, Diabetes Care.

[719]  E. Manzato,et al.  Levels and physicochemical properties of lipoprotein subclasses in moderate hypertriglyceridemia. , 1993, Clinica chimica acta; international journal of clinical chemistry.

[720]  P. Vokonas,et al.  Relationship of dietary saturated fatty acids and body habitus to serum insulin concentrations: the Normative Aging Study. , 1993, The American journal of clinical nutrition.

[721]  M. Laakso,et al.  Effects of Two Fat‐Modified Diets on Glucose and Lipid Metabolism in Healthy Subjects , 1993, Annals of the New York Academy of Sciences.

[722]  G. Lewis,et al.  Effects of Acute Hyperinsulinemia on VLDL Triglyceride and VLDL ApoB Production in Normal Weight and Obese Individuals , 1993, Diabetes.

[723]  R. Heine.  Dietary Fish Oil and Insulin Action in Humans , 1993, Annals of the New York Academy of Sciences.

[724]  J. Hendriks,et al.  Identification of multiple dense LDL subfractions with enhanced susceptibility to in vitro oxidation among hypertriglyceridemic subjects. Normalization after clofibrate treatment. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[725]  [Physical activity and the metabolic syndrome]. , 1993, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[726]  Martin G. Larson,et al.  Long-Term Epidemiologic Prediction of Coronary Disease , 1993 .

[727]  B. Spiegelman,et al.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.

[728]  W. Kannel,et al.  Long-term epidemiologic prediction of coronary disease. The Framingham experience. , 1993, Cardiology.

[729]  J. Després,et al.  Abdominal obesity as important component of insulin-resistance syndrome. , 1993, Nutrition.

[730]  S. Grundy,et al.  Comparison of Effects of High and Low Carbohydrate Diets on Plasma Lipoproteins and Insulin Sensitivity in Patients With Mild NIDDM , 1992, Diabetes.

[731]  S. Haffner,et al.  Prospective analysis of the insulin-resistance syndrome (syndrome X). , 1992, Diabetes.

[732]  I. Ilyés,et al.  [Insulin resistance in childhood obesity]. , 1992, Orvosi hetilap.

[733]  A Tremblay,et al.  Visceral Obesity in Men: Associations With Glucose Tolerance, Plasma Insulin, and Lipoprotein Levels , 1992, Diabetes.

[734]  A. Whelan,et al.  The effect of aspirin on niacin-induced cutaneous reactions. , 1992, The Journal of family practice.

[735]  E. Yetley,et al.  Nutrient intakes and body weights of persons consuming high and moderate levels of added sugars. , 1992, Journal of the American Dietetic Association.

[736]  G. Reaven,et al.  Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. , 1991, JAMA.

[737]  P. Björntorp.  Metabolic Implications of Body Fat Distribution , 1991, Diabetes Care.

[738]  J. Albu,et al.  Effect of exercise training on insulin sensitivity and glucose metabolism in lean, obese, and diabetic men. , 1991, Journal of applied physiology.

[739]  W. Haskell,et al.  Saturated Fat Intake and Insulin Resistance in Men With Coronary Artery Disease , 1991, Circulation.

[740]  R. Hamman,et al.  High-fat, low-carbohydrate diet and the etiology of non-insulin-dependent diabetes mellitus: the San Luis Valley Diabetes Study. , 1991, American journal of epidemiology.

[741]  E A Anderson,et al.  Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. , 1991, The Journal of clinical investigation.

[742]  M. Nikkilä.  Influence of fish oil on blood lipids in coronary artery disease. , 1991, European journal of clinical nutrition.

[743]  R. DeFronzo,et al.  Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease , 1991, Diabetes Care.

[744]  D. Chisholm,et al.  Comparison of the effects on insulin sensitivity of high carbohydrate and high fat diets in normal subjects. , 1991, The Journal of clinical endocrinology and metabolism.

[745]  S. Eisenberg,et al.  Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia. , 1991, The Journal of clinical investigation.

[746]  D. Panciera,et al.  Epizootiologic patterns of diabetes mellitus in cats: 333 cases (1980-1986). , 1990, Journal of the American Veterinary Medical Association.

[747]  H. Kemper,et al.  Tracking of health and risk indicators of cardiovascular diseases from teenager to adult: Amsterdam Growth and Health Study. , 1990, Preventive medicine.

[748]  M. Saad,et al.  Insulin resistance in essential hypertension. , 1990, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[749]  D. Illingworth,et al.  The hypolipidemic effects of gemfibrozil in type V hyperlipidemia. A double-blind, crossover study. , 1989, JAMA.

[750]  R. Bergman.  Toward Physiological Understanding of Glucose Tolerance: Minimal-Model Approach , 1989, Diabetes.

[751]  M. Laakso,et al.  Essential hypertension and insulin resistance in non‐insulin‐dependent diabetes , 1989, European journal of clinical investigation.

[752]  M. Jensen,et al.  Insulin Regulation of Lipolysis in Nondiabetic and IDDM Subjects , 1989, Diabetes.

[753]  R. Eckel,et al.  Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases. , 1989, The New England journal of medicine.

[754]  B. Isaksson,et al.  Dietary habits and incidence of noninsulin-dependent diabetes mellitus in a population study of women in Gothenburg, Sweden. , 1989, The American journal of clinical nutrition.

[755]  N. Kaplan.  The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. , 1989, Archives of internal medicine.

[756]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[757]  R. Zechner,et al.  Dietary polyunsaturated fats of the W-6 and W-3 series reduce postprandial lipoprotein levels. Chronic and acute effects of fat saturation on postprandial lipoprotein metabolism. , 1988, The Journal of clinical investigation.

[758]  W. Harris,et al.  Effects of a low saturated fat, low cholesterol fish oil supplement in hypertriglyceridemic patients. A placebo-controlled trial. , 1988, Annals of internal medicine.

[759]  J. Huttunen,et al.  Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. , 1987, The New England journal of medicine.

[760]  S. Lillioja,et al.  In Vivo Insulin Action Is Familial Characteristic in Nondiabetic Pima Indians , 1987, Diabetes.

[761]  R R Wing,et al.  Long-term effects of modest weight loss in type II diabetic patients. , 1987, Archives of internal medicine.

[762]  A. Dyer,et al.  Nutritional therapy for high blood pressure. Final report of a four-year randomized controlled trial--the Hypertension Control Program. , 1987, JAMA.

[763]  D. W. Hayden,et al.  Immunohistochemical morphometry of pancreatic endocrine cells in diabetic, normoglycaemic glucose-intolerant and normal cats. , 1986, Journal of comparative pathology.

[764]  P. Björntorp,et al.  The Influence of Body Fat Distribution on the Incidence of Diabetes Mellitus: 13.5 Years of Follow-up of the Participants in the Study of Men Born in 1913 , 1985, Diabetes.

[765]  K. Uwyyed,et al.  Cardiac arrhythmias during sleep in morbidly obese sleep‐apneic patients before and after gastric bypass surgery , 1985, Clinical cardiology.

[766]  C. von Schacky,et al.  Long-term effects of dietary marine omega-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans. , 1985, The Journal of clinical investigation.

[767]  M. Blaufox,et al.  Dietary therapy slows the return of hypertension after stopping prolonged medication. , 1985, JAMA.

[768]  S. Eisenberg,et al.  Abnormalities in very low, low and high density lipoproteins in hypertriglyceridemia. Reversal toward normal with bezafibrate treatment. , 1984, The Journal of clinical investigation.

[769]  C. Howard.  Nonhuman Primates as Models for the Study of Human Diabetes Mellitus , 1982, Diabetes.

[770]  A. Kissebah,et al.  Relation of body fat distribution to metabolic complications of obesity. , 1982, The Journal of clinical endocrinology and metabolism.

[771]  J. Robertson,et al.  SALT AND HYPERTENSION , 1980, The Lancet.

[772]  J. Vasselli,et al.  Development of obesity in Zucker obese (fafa) rat in absence of hyperphagia. , 1980, The American journal of physiology.

[773]  M. Karvonen,et al.  Dietary prevention of coronary heart disease: the Finnish Mental Hospital Study. , 1979, International journal of epidemiology.

[774]  R. DeFronzo,et al.  The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. , 1975, The Journal of clinical investigation.

[775]  K. Hummel,et al.  Effects of parabiosis of normal with genetically diabetic mice. , 1969, The American journal of physiology.

[776]  S. Dayton,et al.  Diet high in unsaturated fat. A controlled clinical trial. , 1969, Minnesota medicine.

[777]  A. Keys,et al.  Serum cholesterol response to changes in dietary lipids. , 1966, The American journal of clinical nutrition.

[778]  D. Kipnis,et al.  Abnormalities in carbohydrate tolerance associated with elevated plasma nonesterified fatty acids. , 1965, The Journal of clinical investigation.

[779]  E. Newsholme,et al.  The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. , 1963, Lancet.

[780]  J. Neel.  Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? , 1962, American journal of human genetics.

[781]  J. Hewitt,et al.  The role of lipids and lipoproteins in atherosclerosis. , 1950, Science.